Effect of age and thirty minutes of exercise on prostacyclin/thromboxane A ratios and circulating concentrations of prostacyclin and thromboxane A by NC DOCKS at The University of North Carolina at Greensboro & Todd, Mikel Kent
INFORMATION TO USERS 
The most advanced technology has been used to photograph and 
reproduce this manuscript from the microfilm master. UMI films the 
text uirectly from the original or copy submitted. Thus, some thesis and 
dissertation copies are in typewriter face, while others may be from any 
type of computer printer. 
The quality of this reproduction is dependent upon the quality of the 
copy submitted. Broken or indistinct print, colored or poor quality 
illustrations and photographs, print bleedthrough, substandard margins, 
and improper alignment can adversely affect reproduction. 
In the unlikely event that the author did not send UMI a complete 
manuscript and there are missing pages, these will be noted. Also, if 
unauthorized copyright material had to be removed, a note will indicate 
the deletion. 
Oversize materials (e.g., maps, drawings, charts) are reproduced by 
sectioning the original, beginning at the upper left-hand corner and 
continuing from left to right in equal sections with small overlaps. Each 
original is also photographed in one exposure and is included in 
reduced form at the back of the book. 
Photographs included in the original manuscript have been reproduced 
xerographically in this copy. Higher quality 6" x 9" black and white 
photographic prints are available for any photographs or illustrations 
appearing in this copy for an additional charge. Contact UMI directly 
to order. 
University Microfilms International 
A Bell & Howell Information Company 
300 North Zeeb Road, Ann Arbor, Ml 48106-1346 USA 
313/761-4700 800/521-0600 

Order Number S110077 
Effect of age and thirty minutes of exercise on prostacyclin/thromb 
A2 ratios and circulating concentrations of prostacyclin and 
thromboxane A2 
Todd, Mikel Kent, Ph.D. 
The University of North Carolina at Greensboro, 1990 
U M I  
300 N. Zeeb Rd. 
Ann Arbor, MI 48106 

EFFECT OF AGE AND THIRTY MINUTES OF EXERCISE 
ON PROSTACYCLIN/THROMBOXANE A2 RATIOS 
AND CIRCULATING CONCENTRATIONS 
A Dissertation Submitted to 
the Faculty of the Graduate School at 
The University of North Carolina at Greensboro 
in Partial Fulfillment 
of the Requirements for the Degree 
Doctor of Philosophy 
OF PROSTACYCLIN AND 
THROMBOXANE A2 
by 
Mikel Kent Todd 
Greensboro 
1990 
Allan 
Approved by 
} 
APPROVAL PAGE 
This dissertation has been approved by the following 
committee of the Faculty of the Graduate School at The 
University of North Carolina at Greensboro. 
A /f?o 
Da£e op Acceptance by Committee 
A /fyo 
Final Oral Examination 
• • 
11 
TODD, MIKEL KENT, Ph.D. Effect of Age and Thirty Minutes of 
Exercise on Prostacyclin/Thromboxane A2 Ratios and 
Circulating Concentrations of Prostacyclin and Thromboxane 
A2. (1990) Directed by Dr. Allan H. Goldfarb. 121 pp. 
The effect thirty minutes of treadmill exercise on 
prostacyclin/thromboxane A2 (PGI2/TXA2) ratios, plasma PGI2 
and TXA2 in young and older men, 27.8 + 0.8 and 55.4 + 1.3 
years old, respectively, was determined. Exercise intensity 
was maintained at 70-75% of V02max. Venipuncture samples 
were taken at rest, immediately after exercise, and at thirty 
minutes recovery. Total cholesterol (TC), high density 
lipoprotein (HDL), and low density lipoprotein (LDL) were 
determined from a serum sample taken at rest. Plasma 6-keto-
prostaglandin F1#d and TXB2 (i.e. stable metabolites of PGI2 
and TXA2# respectively) were determined by radioimmunoassay. 
Plasma PGI2 and TXA2 were corrected for hemoconcentration; 
TXA2 was corrected for platelet count. Linoleic acid (LLA) 
intake and polyunsaturated/saturated fat ratios (P/S ratios) 
were estimated by four-day diet records. 
Repeated measures ANOVA indicated that there was a 
significant main effect for age on PGI2/TXA2 ratios and TXA2 
concentrations. Resting PGI2/TXA2 ratios were 7.4 + 1.4 for 
the young men and 5.9 + 1.0 for the older men; the ratios 
were not significantly different. Immediate-post exercise 
ratios changed 25.4% and 10.3% for the young and older men, 
respectively. The difference was not significant. Thirty 
minutes after exercise PGI2/TXA2 ratios for the older men 
were 37.5% below resting levels, compared to an 8.2% decline 
for the young men. There was an 85.2% difference between 
group ratios thirty minutes after exercise; the difference 
was not significant. Ratio changes for the older men thirty 
minutes after exercise were marked by a 28.7% increase in 
TXA2 above resting values. Seperately adding TC, HDL, LDL, 
LLA and P/S ratios as covariates did not alter the analysis. 
These data suggest that older men may experience declines 
in PGI2/TXA2 below resting values thirty minutes following 
exercise at 70-75% of V02max. Thus, older men, when compared 
to younger men, may be more predisposed to platelet 
aggregation thirty minutes after exercise. 
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CHAPTER I 
INTRODUCTION 
Statement of the Problem 
Clinical manifestations of coronary heart disease include 
angina# myocardial infarction and sudden death. Researchers 
report that these and other ischemic events may be initiated 
by platelet aggregation resulting from platelet contact with 
damaged endothelial tissue (Davies, & Thomas, 1984; Freeman, 
Williams, Chisholm, & Armstrong, 1989). 
During the past decade much attention has been focused 
on the role of two prostanoids, thromboxane A2 (TXA2) and 
prostacyclin (PGI2), in regulating platelet aggregation. 
Thromboxane A2 is released from platelets and stimulates 
platelet aggregation; PGI2 is released from endothelial 
tissue and inhibits platelet aggregation. Thromboxane A2 is 
released when platelets come in contact with damaged 
endothelial tissue. This response may serve to protect the 
circulation by limiting blood loss and facilitating tissue 
repair. Prostacyclin, when released by the endothelium works 
to inhibit platelet aggregation. However, if the endothelial 
lining is sufficiently damaged, as in the presence of 
atherosclerotic plaque, PGI2 release into the circulation may 
be too limited to inhibit platelet aggregation. Under these 
conditions, the platelet clump may become large enough to 
impede blood flow and the clinical manifestations of 
myocardial ischemia may result. 
Monocada and Vane (1979) suggested that the ratio between 
circulating concentrations of PGI2 and TXA2 has an important 
role in determining the extent of platelet aggregation; and, 
the lower the PGI2/TXA2 ratio the greater the predisposition 
towards platelet aggregation. Researchers have typically 
reported PGI2 and TXA2 concentrations separately, not as 
ratios. Thus, there is. insufficient data available to 
determine what is normal for PGI2/TXA2 ratios. 
Factors reported to independently influence circulating 
concentrations of PGI2 and TXA2 include: age, exercise and 
diet. Extensive research pertaining to the effect of age on 
in vitro prostanoid synthesis has been conducted. Vascular 
tissues removed from young laboratory animals have been found 
to release greater amounts of PGI2 than vascular tissue 
extracted from older animals (Kent, Kitchell, Shand & 
Whorton, 1981; Chang & Tai, 1983). Giani et al. (1985) 
reported that platelets from younger rats synthesized less 
TXA2 than platelets from older rats. These findings suggest 
that older animals may be more predisposed to platelet 
aggregation than younger animals. 
The effect of age on in vivo concentrations of PGI2 and 
TXA2 in humans is less clear. Researchers report that 
circulating concentrations of both PGI2 and TXA2 increase 
with age; however, they do not indicate how these changes 
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affect PGI2/TXA2 ratios (Reilly & FitzGerald, 1986? Vericel, 
Croset, Sedivy, Courpron, Dechavanne & LaGarde, 1988). A 
review of the mean data from these studies suggests that 
PGI2/TXA2 ratios are either unaffected (Reilly & FitzGerald, 
1986) or decline as age increases (Vericel, Croset, Sedivy, 
Courpron, Dechavanne & LaGarde, 1988). Further investigation 
of the effect of age on PGI2/TXA2 ratios in humans is 
warranted. 
Exercise has been associated with increases in 
circulating concentrations of PGI2 (Demers, Harrison, Halbert 
& Santen; 1981; Piret et al, 1990) and TXA2 (Laustiola, 
Seppala, Nikkari & Vapaatalo, 1984; Taniguchi, Furui, 
Yamauchi & Sotobata, 1984). Other researchers report no 
change (Viinikka, Vuori & Ylikorkala, 1984) or a decline in 
PGI2 (Taniguchi, Furui, Yamauchi & Sotobata, 1984), and no 
change in TXA2 (Metha, Metha & Hovalek, 1983; Viinikka, Vuori 
& Ylikorkala, 1984) in response to exercise. Rauramaa (1987) 
suggested that inconsistencies among these studies may be due 
to different modes, intensities and durations of exercise 
used to stimulate prostanoid changes. Also, some of these 
studies involved subjects representing a wide range of ages 
(Demers, Harrison, Halbert & Santen, 1981; Metha, Metha & 
Horalek, 1983) or primarily young subjects (Piret et al., 
1990). Research comparing the effects of exercise on PGI2 
and TXA2 among or between different age groups is needed 
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since age may influence circulating concentrations of PGI2 
and TXA2. 
The dietary precursor for both PGI2 and TXA2 is linoleic 
acid, which is found in most vegetable oils. Linoleic acid 
intake within the range of six to ten percent of total energy 
intake is desirable for proper PGI2 and TXA2 synthesis 
(Dupont, 1987). Variations in fatty acid intake may lead to 
differences in PGI2 and TXA2 synthesis. Therefore, 
assessment of dietary intake of linoleic acid should provide 
valuable information to anyone investigating the effects of 
age and exercise on circulating concentrations of these 
prostanoids. 
The influence of chronic exercise (i.e. aerobic exercise 
at least twenty minutes per day, three days per week) and 
diet on prostanoid synthesis may be partially mediated by 
their effect on plasma lipoproteins (Leon, 1988). High 
density lipoproteins (HDL) have been reported to be 
positively associated with PGI2 synthesis; whereas, low 
density lipoproteins (LDL) have been reported to be inversely 
associated with PGI2 production (Beitz & Forster, 1980). 
Therefore, assessment of the influence of serum lipoprotein 
concentrations may provide insight into differences in plasma 
PGI2 and TXA2 due to age or acute exercise. 
Age, exercise, and diet may have an indirect role in 
platelet aggregation as a consequence of their influence on 
PGI2 and TXA2. Elucidation of the combined effects of age, 
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exercise and diet on PGI2 and TXA2 may further clarify why 
older adults are at higher risk of ischemic events associated 
with exercise. 
Purpose 
The purpose of this study was to evaluate whether or not 
there is a statistically significant difference between the 
circulating PGI2/TXA2 ratio in young adult males (25 and 35 
years old) and older adult males (50 and 65 years old) during 
rest, exercise and recovery from exercise. Individual 
concentrations of both PGI2 and TXA2 were reported to help 
clarify the interpretation of any changes observed in the 
PGI2/TXA2 ratio. Also, since dietary intake of linoleic 
acid, the polyunsaturated to saturated fat ratio (P/S ratio), 
HDL and LDL are known to affect PGI2 and TXA2 these factors 
were examined. 
Hypotheses 
The researcher hypothesized that upon comparison of the 
two age groups: 
1. There would be no significant difference between 
maximal oxygen consumption (V02max), highest heart 
rate achieved during the maximal exercise test, and 
the percent oxygen consumption (%V02) during sub-
maximal exercise. 
2. There would be no significant difference between 
PGI2/TXA2 ratios, plasma PGI2, or plasma TXA2 during 
rest, exercise, or recovery. 
3. There would be no significant difference between 
PGI2/TXA2 ratio, plasma PGI2, or plasma TXA2 during 
rest, exercise, or recovery when total serum 
cholesterol was used as a covariate. 
4. There would be no significant difference between 
PGI2/TXA2 ratios, plasma PGI2, or plasma TXA2 during 
rest, exercise, or recovery when serum HDL was used 
as a covariate. 
5. There would be no significant difference between 
PGI2/TXA2 ratios, plasma PGI2, or plasma TXA2 during 
rest, exercise, or recovery when serum concentration 
of LDL was used as a covariate. 
6. There would be no significant difference between 
PGI2/TXA2 ratios, plasma PGI2, or plasma TXA2 during 
rest, exercise, or recovery when dietary linoleic 
acid was used as a covariate. 
7. There would be no significant difference between 
PGI2/TXA2 ratios, plasma PGI2, or plasma TXA2 during 
rest, exercise, or recovery when the P/S ratio was 
used as a covariate. 
Assumptions and Limitations 
Each subject was asked not to take medications known to 
inhibit prostanoid synthesis during this study. The 
researcher reminded the subjects about this instruction 
during the maximal exercise test session. Also, the 
researcher asked each subject during the sub-maximal exercise 
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session when he had last taken any medications known to 
inhibit prostanoid synthesis. Otherwise the researcher can 
only assume that this instruction was followed. Failure of 
subject compliance to this instruction may have lead to 
erroneous results. 
Generalization of the results are limited by several 
factors. Only subjects determined to be at no or limited 
risk for coronary heart disease participated, as described 
in the methods chapter. No subjects displaying or reporting 
symptoms of coronary heart disease participated. The 
researcher attempted to recruit physically active subjects; 
and, subjects were self-selected. 
Each subject exercised at the same relative intensity; 
but, the absolute workloads were different. The researcher 
did not know, a priori, if the lower absolute workload in the 
older group would be sufficient to alter prostanoid 
concentrations. 
Dietary intake of linoleic acid, polyunsaturated fat and 
saturated fat were evaluated from dietary food records. The 
circulating concentrations of these substances were not 
determined. Consequently, the influence of these dietary 
substances on the circulating concentrations of PGI2 and TXA2 
can only be regarded as statistical estimates. 
Fann et al. (1989) have found regional variability in the 
synthesis of PGI2 among different vessels extracted from 
laboratory animals. In the present study circulating 
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concentrations of PGI2 were measured in blood taken from an 
antecubital vein. Therefore, the concentrations of 
prostacyclin found in the present study should not be 
considered representative of concentrations existing in parts 
of the circulation other than antecubital venous areas. 
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CHAPTER II 
REVIEW OF RELATED LITERATURE 
Prostanoid Structure and Synthesis 
In the early 1930's von Euler and Goldblatt independently 
discovered prostanoids. Von Euler used the term 
"prostaglandin" to describe a substance in human semen 
capable of stimulating smooth muscle contraction and lowering 
blood pressure. The discovery of prostanoids was largely 
ignored until the 1960's when researchers at the Karolinska 
Institute in Stockholm determined the chemical structure of 
the first prostanoid (Cohen, 1985). 
Prostanoids can be synthesized from three different 20-
carbon unsaturated fatty acids: eicosatrienoic acid, 
eicosatetraenoic acid (arachidonic acid) and eicosapentaenoic 
acid. These fatty acids vary in degree of unsaturation. 
Eicosatrienoic acid has three double bonds, arachidonic acid 
has four and eicosapentaenoic acid has five. The prostanoids 
synthesized from these substrates are given series 
designations A through I and a subscript numbers of 1, 2 or 
3. The letter designation denotes the prostanoid's chemical 
configuration. The subscript number denotes the number of 
double bonds present in the prostanoid's two side chains. 
Sometimes the Greek letter alpha or beta follows the 
subscript number. This letter denotes the stereochemistry 
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of the prostanoid at the C9 position. Whereas prostanoids 
retain their 20-carbon backbone indicative of their fatty 
acid substrates, the structure of the side chains is altered. 
The enzymes responsible for synthesizing prostanoids are 
present in most cells and synthesis is apparently stimulated 
by slight alterations in tissue homeostasis (Cohen, 1985). 
PGI2 and TXA2 Structure and Synthesis 
In 1976 researchers discovered that prostaglandin 
endoperoxides were changed by endothelial enzymes into an 
substances with potent anti-aggregatory properties. They 
later found that this substance relaxed vascular strips in 
vitro, while in vivo it dilated vascular beds and had 
antithrombotic properties. Originally named PGX, it was 
renamed prostacyclin and given the abbreviation PGI2 when 
it's chemical structure was determined by the Wellcome 
Research Laboratory and the Upjohn Company (Cohen, 1985). 
The chemical structure of TXA2 was determined near the 
same time as PGI2. Since TXA2 was first found in platelets 
and determined to promote platelet aggregation it was given 
the name "thromboxane. In opposition to PGI2, TXA2 has 
potent aggregatory properties. Thus, the PGI2/TXA2 ratio is 
believed to have a profound influence on platelet 
aggregation. 
Arachidonic acid (AA) is the precursor for both PGI2 and 
TXA2 (Figure 1). Arachidonic acid may be supplied directly 
by the diet or synthesized from the 18-carbon linoleic acid 
Figure 1. Prostaglandin Metabolism 
11 
Linoleic Acid I 
Arachidonic Acid 
(Cyclo-oxygenase) 
PGG2 
(Peroxidase) 
#>>J 
 
s 
PGH2 
(TXA2 synthase) 
TXA2 
PGD2 
TXB2 
(stable metabolite 
ofTXA2) 
(PGI2 synthase) 
6-keto-PGFl 
(Stable metabolite 
of PGI2) 
12 
which is present in most vegetable oils. The first steps in 
PGI2 and TXA2 synthesis are catalyzed by cyclooxygenase and 
peroxidase. Cyclooxygenase is responsible for the 
cyclization and oxygenation of AA into the unstable 
intermediate prostaglandin G2 (PGG2). Peroxidase facilitates 
the change of PGG2 into prostaglandin H2 (PGH2), which is 
also an unstable intermediate. Prostaglandin G2 and PGH2 are 
frequently referred to as cyclic endoperoxides (Cohen, 1985). 
Several tissue enzymes are capable of acting upon PGH2. 
Prostaglandin I2 synthetase changes PGH2 into PGI2 and TXA2 
synthetase converts PGH2 to TXA2, respectively. 
Prostaglandin I2 synthetase is present in blood vessel walls, 
with the greatest portion found in the endothelium. 
Thromboxane A2 synthetase is primarily found on platelet 
surfaces (Cohen, 1985). 
Influence of Age upon PGI2 and TXA2 
Results from several studies involving animal models 
indicate that PGI2 synthesis is inversely associated with 
age; whereas, TXA2 synthesis remains unchanged or increases 
with age. An outline the studies investigating the effect 
of age on PGI2 and TXA2 in animals is presented in Table 1. 
Chang and Tai (1983) reported that aortic rings removed 
from twelve-month-old rats produced significantly more PGI2 
(14.0 + 0.78 ng/mg dry weight) than aortic rings from twenty-
four month old rats (8.8 + 0.76 ng/mg dry weight). No age 
related difference in TXA2 synthesis was found; but, in a 
Table 1. 
Age and Prostanoids in Animals 
Reaeirclien Qatc Research model Treatment 
Chang et al. 1980 
Chang 
& TaT 
1983 
Giani et al. 1985 
Kent et al. 
Menconi 
et al. 
1981 
1987 
Fanganamala 
et alT 
1981 
aortic cells from 
12 & 24 month old 
male Fischer rats 
aortic cells and 
platelets from 2, 12 
& 24 month old male 
Fischer rats 
aortic cells and platelets 
from 1& 11 month old 
Spragoe Dawley rats 
aortic cells from 
6 month and 2-4 
year old swine 
aortic cells from neo­
natal 13 & 30 month 
old Sprague Dawley 
rats 
cuItur«f̂ om*̂ /ne; 12 
& 108 population 
doublings (PD) 
adventitial fibroblasts 
from swine; 13 & 65 
PD 
aortic cells from 
3 to 20 week old 
Sprague Dawley rats 
30 min incubation in 
arachidonic acid (AA) 
aortic cells: 30 min 
incubation in AA; 
platelets: 2 min 
incubation in AA 
aortic cells: perfused with 
plasma; platelets: 5 min 
incubation in collagen 
30 min incubation in AA 
20 min incubation in 
bradykinin or 
ionophore A23187 
30 min incubation in AA 
30 min incubation in AA 
30 min incubation in AA 
N.A. = not available 
w = week 
m = month 
PCI* 
PGI2/PGE2 ratio 
12 m: 2.40 ±.05 
24 m: 0.67 ± .06 
TxA* 
N.A. 
if" 
12 m: 14.0 ± A 
24 m: 8.8 ± .8 
is 
12 m: 34 ± 6.5 
24 m: 117 ± 10.6 
perfused (pg/ul) 
I m: 6.6 ± 0.8 
II m: 14.6 ± 2.4 11 m: 85.9 ± 10.8 
(ng/gm of tissue) 
6 m: 3299 ±437 
2-4 y: 1706 ± 252 
N.A. 
PGI2 n PGE2 
neo.: PGI2 > PGE2 
13m: PGI2 = PGE2 
30m: PGI2 < PGE2 
N.A. 
(ng/ml) 
12 PD: 132.0 ± 12.0 
108 PD: 1.8 ± 0.2 
N.A 
(ng/ml) 
13 PD: 13 ± 0.1 
65 PD: OS ± 0.1 
N.A. 
(pm/ng of tissue) 
Jw: ft 17 
12 w: <f 32 
20 w: @60 
N.A. 
H 
w 
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similar study Giani, Masi and Galli (1985) found that 
platelets taken from eleven month old rats produced 
significantly more TXA2 (85.9 + 10.8 pg/ul) than platelets 
from one month old rats (43.6 + 2.9 pg/ul). Kent et al. 
(1981) reported significantly greater PGI2 production in 
aortic tissue from six month old swine (3299 + 437 ng/gm) 
when compared with two to four year old swine (1706 + 252 
ng/gm). The differences found by Kent et al. (1981) existed 
only when arachidonic acid was present in high 
concentrations. Thromboxane A2 was not measured in this 
study. 
The influence of age upon prostanoid synthesis has also 
been studied in vitro. Chang et al. (1980) found that while 
total prostanoid synthesis was similar between cell cultures 
from twelve and twenty-four month old rats, significantly 
more PGI2 was synthesized in the cultures from the twelve 
month old rats. Cell cultures from the twenty-four month old 
rats produced greater quantities of prostaglandin E2 (PGE2) 
than PGI2. The PGI2/PGE2 ratios were reported as 2.4 + 0.05 
and 0.67 + 0.062 for the young and old rats, respectively. 
In the same study, Chang et al. (1980) bypassed several steps 
in the linoleic acid pathway by adding PGH2 directly to the 
cell cultures from each group. The researchers reported that 
the cultures from the twelve month old rats converted six 
times as much of the PGH2 to PGI2 than the cultures from the 
twenty-four month old rats. These data suggest that the 
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enzyme responsible for conversion of PGH2 to PGI2 was less 
active in the older cultured cells. Chang et al. (1980) did 
not measure TXA2. 
Menconi et al. (1987), grew smooth muscle cells in 
culture from neonatal, thirteen month old and thirty month 
old rats. After twenty minutes exposure to bradykinin or 
ionophore A23187, both stimulants of PGI2 synthesis, 
prostanoid products were analyzed. Prostaglandin I2 
synthesis was highest in the neonatal rat cultures and lowest 
in the thirty month old rat cultures. Menconi et al. (1987) 
also investigated PGI2 production in the microvasculature and 
the relationship of such production to age. The researchers 
reported that PGI2 production decreased with age. Menconi 
et al. (1987) did not provide quantitative results. 
Tissue cultures of human skin fibroblast represent 
another research model that investigators have used to 
examine the relationship of PGI2 synthesis to age. This 
research model is useful because human skin fibroblast are 
known to have doubling capacities limited by age. Taylor et 
al. (1981) found that tissue cultures which underwent a 
greater number of doublings (i.e. older cultures) synthesized 
significantly less PGI2 than cultures which underwent fewer 
doublings (i.e. younger cultures). In this study tissue 
cultures were stimulated separately with AA, ascorbic acid, 
and bradykinin. In each case, PGI2 concentrations after 
stimulation were lower in the older cultures. In a similar 
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study, Polgar and Taylor (1980) found that younger human 
embryo lung fibrobl^ ?t cultures synthesized a greater 
quantity of PGI2 (0.92 + 0.08 ng/ml) when compared to older 
cultures (0.53 + 0.03 ng/ml). In addition, the older 
cultures synthesized greater amounts of TXA2 and PGE2; while 
the oldest cultures synthesized predominantly prostaglandin 
(PGFlot ). Chan et al. (1975) suggested that PGFlot can 
be synthesized non-enzymatically. Thus, the findings by Chan 
et al. (1975) and Polgar and Taylor (1980) support the theory 
that the influence of aging upon the production of PGI2 may 
be mediated by a reduction in PGI2 synthetase activity. 
Only a few studies involving the investigation of PGI2 
and TXA2 concentrations in humans have been conducted. These 
studies are outlined in Table 2. 
Hanley and May (1985) investigated PGI2 synthesis by 
saphenous venous tissue removed from patients undergoing 
varicose vein surgery. These investigators found no 
relationship between PGI2 synthesis and age. The results of 
this investigation, however, may have been confounded by the 
fact that many of the patients were smokers. Several 
researchers have reported that smoking may inhibit PGI2 
synthesis (Pittilo, Mackie, Rowles, Machin & Woolf, 1982; 
Sonnenfeld & Wennmalm, 1980; Wennmalm, 1980). 
The results from studies investigating in vivo 
concentrations of PGI2 and TXA2 in apparently healthy humans 
are not consistent. Although researchers have reported that 
Table 2. 
Rfflwrdicni Date flahtctin 
Age and Prftstanoids in Healthy Humans 
Treatment TEA? 
Hanlej ft 1985 saphenous Tenons tissue 
May from 51 men and 117 
women having varicose 
vein removal; 17 to 70 
years old 
30 mln incubation in 
buffer 
(smokers included) 
No significant re* 
lationship between 
age and PGI2 
concentrations 
N.A. 
Reilly ft 
FitzGerald 
1986 12 (8 males + 4 females) 
21 - 39 years old (Y); 20 
(10 males + 10 females) 
50 - 88 years old (O) 
resting; urinary PGI2 and 
TXA2 
resting; serum TXA2 
(pg/mg creatinine) 
Y: 121 ±13 
O: 197 + 21 
(pg/mg creatinine) 
Y: 152 ±19 
O: 223 ±22 
(ng/ml) 
Y: 367 ±33 
O: 327 ±43 
Yerkel et al. 1988 8 (sex not given), 25-35 
year olds (Y); 16 (sex not 
given), 78 - 94 year olds 
resting; urinary PGI2 and 
TXA2 
resting; serum PGI2 and 
TXA2 
resting; TXA2 stimulated 
with thrombin 
(ng/mole creatinine) 
Y: 116 ± 42 
O: 193 ±118 
(nmoles/ml) 
Y: 13.3 ± 8.1 
O: 27.2 ± 14.8 
N.A. 
(ng/mole creatinine) 
Y: 25.1 ± 14.5 
O: 515 ±43 2 
(nmoles/ml) 
Y: 0.49 ±. 0.18 
O: 0.28 ± 0.19 
(nmoles/109 platelets) 
Y: 0.65 ±.0.22 
O: 1.09 ± 0.52 
N.A. s not available 
Y = young subjects 
O = older subjects 
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urinary concentrations of both PGI2 and TXA2 increase with 
age (Reilly & FitzGerald, 1986; Vericel, Croset, Sedivy, 
Courpron, Dechavanne, & LaGarde, 1988), the influence of 
these age related changes on the PGI2/TXA2 ratio vary. Based 
on the mean data reported by Reilly and FitzGerald (1986) the 
ratio was similar in both age groups; whereas, the data from 
the study by Vericel et. al. (1988) suggest that the ratio 
was lower in the older age group. 
In summary, the results from research conducted in vitro 
and with tissue samples from animals suggest that PGI2 
synthesis is inversely associated with age, and that TXA2 
synthesis is unaffected by age. In vivo studies involving 
apparently healthy humans do not entirely support these 
findings, although there are some consistencies suggestive 
of an age related reduction in the PGI2/TXA2 ratio. 
Exercise and Prostanoids 
Only the studies involving the acute effects of exercise 
on prostanoids will be reviewed, although researchers have 
investigated the effects of both acute and chronic exercise 
on prostanoids. This review is also limited to studies 
involving apparently healthy subjects. An outline of the 
research investigating the effects of acute exercise on PGI2 
and TXA2 in apparently healthy individuals is presented in 
Table 3. 
In 1981, Demers et al. found that plasma PGI2 was 
significantly higher in athletes immediately following a 
Table 3. 
Exercise and Prostanoids in Healthy Humans 
IflMHlWN Treatment PCI* TXA* 
Carter etal. 1989 12 male athletes; 
23.7 £ 3.4 years old; 
V02max: 562, ± 5.7 
ml/kg/mln 
15 min cycling at 30% 
of V02max; before exer­
cise (BE); during exercise 
(DE); after exercise (AE) 
(pg/min plasma) 
BE: 2.92 ±0.62 
DE: 6.16 ± 1.87 
AE: 3.16 ± 0.59 
(nmol/1 plasma) 
BE: 6.40 ± 2 .38 
DE: 9.64 ± 3.45 
AE: 13.01 ± 5.34 
9 male runners: 
31 ± 6 years old 
21 to 42 km run; before 
race (BR); immediately 
after race (IR) 
(pg/min plasma) 
BR: 1.62 ± 0.30 
IR: 1.08 + 024 
(nmol/1 plasma) 
BR: 6.88 ± 1.24 
IR: 8.48 ±1.65 
Doners 
et al. 
1981 20 males; 40 ± 10 years; 
4 females; 37 ± 7 years 
42 km run (pg/ml plasma) 
BR: 2161 ± 335 
AR: 4462 ± 2405 
N.A. 
Laostlola 
et al. 
1984 6 males; moderately 
trained; 19 - 23 years old 
exhaustive exercise at 50% 
of "maximal aerobic ca­
pacity"; immediately after 
exercise (IEh 30 mm after 
exercise (AE) 
(% of resting value) 
lE: 40% above rest 
AE: 10% above rest 
N.A. 
IE: @ 250 
AE: @275 
SB^y" 
IE: @50 
AE: @75 
Metha et al. 1983 13 males; 22 • 65 years 
old 
maximal exercise test 
10 min minumum; peak 
exercise (PE); 15 • 30 
after exercise (AE) 
j /̂m^jtlasma) 
PE: 175 ±57 
AE: 61 ±19 
iBftlSS* 
PE: 168 ±42 
AE: 97 ±22 
N.A. = not available 
H 
to 
Table 3. (continued) 
Exercise and Prostanoids in Healthy Humans 
Date Treatment pr.h TXA<» 
Piret et al. 1990 10 males; 212 ± 01 
years old; untrained 
cycle exercise to ex­
haustion; 1 hour after 
exercise (AE) 
(pg/mg creatinine) 
BE: 55 
AE: 131 
N.A. 
Tanigachi 
et al. 
1984 26 males; 21 • 41 
years old; 
treadmill exercise at 85% 
predicted maximal heart 
rate for 12 min; 30 min 
after exercise (AE) 
fnc/ml plasma) 
BE: 1.12 ± 0.2 
IE: 1.00 ±0.17 
AE: 1.34 ±0.36 
ttrtrftTT* 
IE: 118 ± 21 
AE: 118 ± 27 
Todd et al. 1990 6 males; 27.3 years old treadmill exercise at 60%, 
. 70% and 80% of ViCtymax 
for 30 min 
j /̂ml jriasma) 
IE60: 512 
IE70: 430 
IE80: 389 
^ml̂ asma) 
IE60: 523 
IE70: 612 
IE80: 644 
Viinikka 
et al. 
1984 10 runners; (9 male + 
1 female); 18-30 years 
old; 10 controls 
cycle exercise to ex­
haustion; 7 min of exer­
cise (DE); 30 min after 
exercise (AE) 
(pmol/l plasma) 
BE: 1918 ±51.7 
DE: 260.5 ± 86.9 
IE: 2143 ±623. 
AE: 170.6 ±45.7 
(nmol/I serum) 
BE: 703J ± 290.1 
DE: 810.8 ± 326.2 
IE: 798.9 ±206.1 
AE: 1113 ± 213.0 
N.A. s not available 
to 
o 
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marathon run. Plasma P6I2 was 2161 + 335 pg/ml before 
exercise and 4462 + 2405 pg/ml following exercise. These 
researchers did not measure TXA2 levels. Viinikka et al. 
(1984) studied the effects of ten to fourteen minutes of 
exhaustive exercise on circulating prostanoids. They found 
that plasma PGI2 concentrations in marathoners before (192.8 
+ 51.7 pmol/L) and after (214.3 + 62.2 pmol/L) stationary 
cycling were not significantly different from concentrations 
found in non-exercising controls (206.1 +75.7 pmol/L). At 
the seventh minute of exercise, however, plasma PGI2 was 
significantly greater than resting values (260.5 + 86.9 
pmol/L). Thirty minutes following exercise plasma PGI2 
(170.6 + 45.7 pmol/L) tended to be lower than pre-exercise 
concentrations. Viinikka et al. (1984) reported a fifteen 
percent increase in serum TXA2 during exercise. This 
increase was not significant. In contrast, Laustiola et al., 
(1984) found that among well-trained distance runners plasma 
TXA2 increased during exhaustive exercise on a cycle 
ergometer. A graphic display of the data indicated that 
resting plasma TXA2 was approximately 135 pg/ml; at 
exhaustion plasma TXA2 was approximately 260 pg/ml. 
Laustiola et al. (1984) also reported that plasma PGI2 
increased 40 percent when exercising subjects reached 
exhaustion. 
In a study where subjects exercised on a treadmill at 
approximately 85 percent of their age predicted maximal heart 
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rate, Taniguchi et al. (1984), reported that plasma PGI2 
tended to decrease and plasma TXA2 tended to increase. These 
changes were not significant. In a similar study, Metha et 
al. (1983) evaluated changes in plasma PGI2 and TXA2 in 
response to sub-maximal treadmill exercise at approximately 
60% of the subjects' age predicted maximal heart rate. At 
rest PGI2 and TXA2 concentrations were 54 + 17 pg/ml and 135 
+ 30 pg/ml, respectively. These researchers reported that 
PGI2 increased significantly during exercise (175 + 57 
pg/ml). Thromboxane A2 tended to increase (168 + 42 pg/ml), 
but the change was not significantly different from resting 
values. 
Discrepancies in the results between studies using 
different exercise protocols prompted Todd et al. (1990) to 
investigate the effect of exercise intensity on circulating 
PGI2 and TXA2. Resting PGI2 was 384 + 68 pg/ml and TXA2 was 
147 + 56 pg/ml. Exercise-induced alterations in plasma PGI2 
were not significantly affected by exercise intensity, 
although they tended to be inversely related to intensity. 
Plasma PGI2 at 60, 70, and 80 percent of maximal oxygen 
consumption was 512 + 52, 430 + 55, and 389 + 83 pg/ml, 
respectively. Increases in serum TXA2 appeared to be 
positively associated with exercise intensity, although 
exercise did not have a statistically significant effect. 
Serum TXA2 at 60, 70, and 80 percent of maximal oxygen 
consumption was 523 + 117, 612 + 155, and 644 + 122 pg/ml, 
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respectively. Thirty minutes after exercise at 80 percent 
of maximal oxygen consumption TXA2 (918 + 188 pg/ml) was 
significantly greater than the pre-exercise concentration and 
the 60 (600 + 138 pg/ml) and 70 (549 + 132 pg/ml) percent 
concentrations observed at the same time. One weakness in 
the study conducted by Todd et al. (1990) was that blood was 
collected with the aid of an intravenous catheter and no data 
controlling for the effects of the catheter on prostanoid 
concentrations was collected. 
Carter et al. (1989) conducted two separate studies 
intended to contrast the effects of different types of 
exercise on circulating concentrations of PGI2 and TXA2. 
These researchers found that during fifteen minutes of 
cycling at 30% of V02max subjects experienced a two-fold 
increase in plasma PGI2 and a 50% increase in plasma TXA2. 
Immediately following exercise PGI2 returned to near resting 
concentrations and TXA2 concentrations continued to rise to 
twice resting values. Only the two-fold increase in plasma 
TXA2 immediately following exercise was significantly 
different from resting concentrations. Carter et al* (1989) 
also reported that following a 21 to 42 kilometer race both 
PGI2 and TXA2 concentrations were not significantly different 
than resting values. One weakness with the study by Carter 
et al. (1989) is that it was difficult to determine whether 
the type, intensity or duration of exercise was related to 
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the different results since each of these factors were 
different in the two studies. 
Several researchers have suggested that the invasive 
nature of blood sampling may result changes in circulating 
prostanoids. This possibility has lead some researchers to 
investigate the effects of exercise on PGI2 and TXA2 by 
measuring urinary concentrations of these prostanoids. 
Wennmalm and FitzGerald (1988) reported that urinary PGI2 was 
significantly greater than resting concentrations (74 + 14 
pg/mg creatinine) following two hours of exercise (267 + 70 
pg/mg creatinine) at 50 percent of the subjects' maximal 
oxygen consumption and following two hours of recovery (213 
+ 35 pg/mg creatinine). In this study, urinary TXA2 was not 
altered by exercise. Piret et al. (1990) also reported that 
urinary PGI2 increased significantly with exercise. At rest 
PGI2 was 55 pg/mg creatinine; PGI2 increase to 131 pg/mg 
creatinine following exhaustive exercise. 
In summary, a review of the research involving the effect 
of exercise on PGI2 and TXA2 indicates that circulating 
concentrations of both of these prostanoids may be altered 
by exercise. Several researchers reported that TXA2 
increased more than PGI2, which would suggest that the 
PGI2/TXA2 ratio declines with exercise. Other studies, 
however, do not support this finding. There is limited 
evidence that the degree of change may be dependent on 
exercise intensity. Finally, the suggestion by some 
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researchers that prostanoid concentrations may be influenced 
by the sampling technique indicates that care must be taken 
when collecting samples and that interpretation of results 
should be made with caution. 
Diet and Prostanoids 
Several dietary factors are known to influence 
circulating prostanoids. These factors include the 
prostanoid substrates, oleic, linoleic and -linolenic 
acids, the P/S ratio and the serum lipoproteins, LDL and HDL. 
Dupont (1987) reported that when dietary intake of 
linoleic acid is within the appropriate range PGI2 synthesis 
is intact. However, when linoleic acid is deficient the 
oleic acid pathway becomes active. The relationship between 
the activity of the oleic and linoleic acid pathways is known 
as the triene/tetraene ratio. In mammals a triene-tetraene 
ratio of 0.2 in total plasma lipids is indicative of linoleic 
acid deficiency. Such deficiency is marked by various skin 
disorders in most mammals and is associated with early 
mortality in rats. Excessive dietary linoleic acid has also 
been associated with premature mortality in rats. 
Dietary intake of less than three percent of total energy 
consumption of linoleic acid has been associated with high 
triene/tetraene ratios and linoleic acid deficiency. Intake 
of linoleic acid between three to six percent of total energy 
consumption has been associated with over production of 
prostanoids. In contrast, linoleic acid consumption between 
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six and ten percent of total energy consumption has been 
associated with normal prostanoid synthesis. Therefore, 
Dupont (1987) recommended that linoleic acid intake range 
between six and ten percent of total energy consumption. 
Linoleic acid metabolism is also influenced by poly­
unsaturated and saturated fat intake. In general, the lower 
the P/S ratio the greater the amount of linoleic acid 
necessary for normal prostanoid synthesis. Thus, Dupont 
(1987) reported that individuals with low P/S ratios should 
consume a greater proportion of foods rich in linoleic acid, 
providing the percent of total energy consumption of this 
nutrient does not exceed ten percent. 
Lipoproteins and Prostanoids 
Several studies have investigated the relationship of 
LDL and HDL to prostanoid synthesis. In a study by Beitz and 
Forster (1980), HDL was positively correlated with porcine 
microsome's capacity to convert PGH2 to PGI2. These 
researchers also found that LDL was inversely correlated with 
the conversion of PGH2 to PGI2. More recently, Beitz et al. 
(1989) studied the effects of HDL on PGI2 and TXA2 formation. 
Consistent with previous findings Beitz et al. (1989) 
reported that HDL stimulated the conversion of PGH2 to PGI2. 
In addition, these researchers reported that HDL inhibited 
the aggregating properties of TXA2. 
Fleisher et al. (1982) found that human HDL added to 
porcine aortic tissue cultures resulted in a significant 
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dose-dependent increases in PGI2 production. No change in 
PGI2 production was associated with any concentration of LDL 
added to cultures. An apparent relationship between the 
effects of LDL and HDL was found by Nordoy et al. (1978). 
In this study, LDL enhanced platelet aggregation while HDL 
inhibited the pro-aggregatory effects of LDL. No measurement 
of PGI2 or TXA2 was performed in this study. 
Gryglewski and Szczeklik (1981) reported that LDL levels 
were associated with the accumulation of lipid peroxides. 
Lipid peroxide accumulation has been associated with aging 
and the inhibition of PGI2 synthesis (Chang, Nagasawa, 
Takeguchi & Sih, 1980; Kent, Kitchell, Shand & Whorton, 
1981). 
In summary, there is sufficient evidence to indicate that 
the dietary intake of linoleic acid, saturated and 
polyunsaturated fat and plasma concentrations of LDL and HDL 
influence concentrations of prostanoids. Consequently, any 
investigation involving comparisons between concentrations 
of prostanoids should include an examination of both lipid 
profiles and dietary factors. 
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CHAPTER III 
METHODS 
Subjects 
Twenty healthy volunteers, ten young men (25 to 35 years 
old) and ten older men (50 to 65 years old), from the 
Greensboro community participated in this study. Each 
prospective subject was informed of the procedures and risks 
associated with participation in this study, and his right 
to terminate participation at any time. The right to 
terminate participation was explained both verbally and in 
written form in accordance to the procedures filed with the 
School of Health, Physical Education, Recreation and Dance, 
Human Subjects review Committee (Appendices A and B). 
Each prospective subject completed a medical history 
before he was allowed to participate (Appendix C). Subjects 
in the older group also obtained written permission from 
their family physician before they were accepted as 
participants (Appendix D). Individuals who smoked or had 
been diagnosed as having coronary heart disease, diabetes or 
any other chronic disease that may have influenced the 
results of this study were not allowed to participate. 
Subjects determined to have symptoms of coronary heart 
disease were not allowed to participate. Symptoms of 
coronary heart disease were determined by the guidelines in 
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Table 1-1 on page 2 of the Guidelines for Exercise Testing 
and Exercise Prescription published by the American College 
of Sports Medicine, 1986. 
Testing Protocol 
Each subject met with the researcher on three occasions. 
The first meeting was held for the purpose of pre-screening 
prospective subjects. During the second meeting each subject 
was required to perform a maximal exercise test; and, during 
the third meeting each subject participated in a sub-maximal 
exercise session. Subjects in the young group were tested 
in the Exercise Physiology Laboratory at the University of 
North Carolina at Greensboro. Maximal exercise testing of 
subjects in the older group was conducted in the Exercise 
Physiology Laboratory under physician supervision or in the 
Student Health Center at the University of North Carolina at 
Greensboro with a physician on the premises. Medical records 
for the older men tested in the Student Health Center were 
assessed by the health center director before these subjects 
were tested. 
In the first meeting all subjects were informed about the 
procedures, risks and benefits associated with participation 
in the present study (Appendices A and B). This meeting took 
place approximately one week before the first exercise 
session. At this time, each subject completed a medical 
history (Appendix C). Each subject was asked to begin using 
Mazola margarine and Mazola cooking oil as a substitute for 
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any margarine or cooking oils they typically used. This 
included margarine or oils used for: baking, spreading on 
breads or other foods, greasing a baking or frying pan, etc. 
Subjects were asked to continue using Mazola margarine and 
cooking oil until they completed participating in the study. 
Subjects were asked to use these Mazola products as a means 
of partially controlling the dietary intake of fatty acids. 
The researcher emphasized that it was important for the 
subject not to alter other eating habits during participation 
in the study. 
During the first meeting each older man was presented 
with a "Physician's Disclosure and Approval Statement" 
(Appendix D) which was completed and returned to the 
researcher before the subject was allowed to participate in 
the study. Older men were provided with a list of 
"Contraindications for Exercise Testing" (Appendix E) during 
the first meeting. Each older subject was instructed to 
deliver the list of contraindications to his physician when 
they met to evaluate whether or not the prospective subject 
was suitable for participation. 
Following completion of the above procedures each subject 
participated in a maximal exercise test on a motorized 
treadmill. This test was conducted to determine maximal 
oxygen consumption, which was used as the basis for 
estimating the sub-maximal workload. Expired air was 
continuously collected for determination of oxygen 
31 
consumption. Samples of expired air were collected for one 
minute each; and, the oxygen and carbon-dioxide content of 
each sample was determined on a Beckmann OM-11 oxygen 
analyzer and a Beckmann LB-2 gas analyzer, respectively. 
Both analyzers were calibrated before each test with 
calibration gases acquired from Air Products. 
During the maximal exercise test each subject began 
running or walking at a speed and grade estimated to be well 
below his maximal exercise capacity. The speed and grade 
were then increased every one to two minutes until the 
subject indicated that he could not continue or until the 
researcher stopped the test. Each maximal exercise test was 
completed within fifteen minutes following the beginning of 
the test. Each older man was continuously monitored by 
twelve-lead electrocardiography (ECG); whereas, the younger 
men were monitored with three-lead ECG. Electrocardiographic 
monitoring complied with the Guideline for Exercise Testing 
and Prescription published by the American College of Sports 
Medicine, 1986. Blood pressure was measured prior to 
beginning the maximal exercise test and the researcher 
attempted to measure blood pressure at least once during each 
stage of this test (Appendix F). 
Following the first exercise test and before the second 
exercise test the subjects were asked to complete a four-
day dietary food record (Bazzarre, 1983). Records were kept 
for two week days (i.e. tuesday and thursday) and both 
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weekend days. Food records were used to estimate each 
subject's intake of linoleic acid, saturated fat and 
polyunsaturated fat. The two weekdays were weighted to 
represent five-sevenths of the total intake during the food 
record period (Appendix G). 
The second exercise test session was conducted within two 
weeks following the first test. Subjects were asked to fast 
overnight the evening preceding the second exercise test. 
Each subject rested a minimum of fifteen minutes immediately 
preceding the second exercise test. During the second test 
each subject walked or ran on the motorized treadmill for 
thirty minutes between 70 and 75 percent of their maximal 
oxygen consumption. Expired air was collected and analyzed 
periodically to insure that subjects were exercising at the 
desired intensity (Appendix H). Subjects were continuously 
monitored with a three-lead ECG. Each sub-maximal test was 
conducted between the hours of 8:00 am and 12:00 noon to 
control for possible diurnal variations (Nadler, J. & J. 
Yamamoto, 1986). 
Blood Sampling 
Three blood samples were drawn during the second visit 
using sterile Vacutainer techniques. The first blood sample 
(i.e. three, ten milliliter Vacutainers) was drawn at least 
fifteen minutes after the subject was rested, the second 
sample (i.e. two, ten milliliter Vacutainers) immediately 
following thirty minutes of exercise, and the third sample 
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(i.e. two, ten milliliter Vacutainers) thirty minutes 
following the completion of exercise. Blood was drawn from 
an antecubital vein with the aid of a tourniquet. Since 
obstruction of blood flow may alter circulating 
concentrations of PGI2 and TXA2 the tourniquet was removed 
before blood was collected into the last Vacutainer. 
Treatment of Blood Samples 
Blood samples used for the determination of prostanoids, 
platelet counts, hemoglobin, and hematocrit were drawn into 
ten milliliter Vacutainers containing .10 microliters of a 
fifteen percent ethylenediaminetetraacetic acid (EDTA) 
solution and .20 microliters of a .40 percent acetylsalicylic 
acid solution. Samples collected for determination of 
lipoproteins were collected in Vacutainers that did not 
contain any anticoagulants. Approximately two milliliters 
of whole blood was removed for the determination of platelet 
count, hemoglobin, and hematocrit. The remaining blood was 
centrifuged immediately at 3000 rpm for fifteen minutes. 
Plasma was extracted and frozen at -70 C until samples were 
assayed. 
Analysis of Blood Samples 
Platelet counts were determined manually using a Unopette 
Microcollection System and hemocytometry. Hemoconcentration 
was determined by the procedures outlined by Dill and Costill 
(1974). Hemoglobin was evaluated according to the procedures 
outlined by Sigma Diagnostics Co. Inc. 
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Plasma levels of PGI2 and TXA2 (i.e. 6-keto-PGFl4i and 
TXB2, the stable metabolites of PGI2 and TXA2, respectively) 
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were determined by A"i radioimmunoassay. Extraction of the 
prostanoids from plasma was conducted in the following 
manner. Seventy-five microliters of a seven percent solution 
of hydrogen chloride was added to one-half milliliter of 
plasma in order to lower the pH of the plasma to between 
three and four. Three volumes of ethyl acetate were added 
to the plasma; and, each sample was mixed thoroughly on a 
vortex mixer. The aqueous and organic phases were separated 
by centrifugation for fifteen minutes at 3000 rpm. The upper 
organic phase containing the prostanoids was removed and the 
ethyl acetate was allowed to evaporate. 
Assays were conducted according to the procedures 
outlined by Advanced Magnetics, Inc. All frozen reagents 
were thawed for 30 minutes before they were used. 
Lyophilized reagents were reconstituted with phosphate buffer 
provided by Advanced Magnetics, Inc. Round bottom 
polypropylene tubes measuring 12 X 75 mm were used for all 
samples and standards. Serial dilutions of the stock 
prostanoid concentrate (100 ng/ml) were distributed into a 
series of six concentrations (i.e. 4.1, 12.3, 37.0, 111.0, 
333.0, and 1000.0 pg/O.lml) to create an assay standard. 
Tubes were labeled in duplicate for determination of total 
count, non-specific binding (NSB), blank (Bo), standards and 
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samples. The remaining assay procedures were conducted as 
follows: 
1. 200 ul of buffer was added to NSB and sample tubes. 
2. 100 ul of buffer was added to Bo tubes. 
3. 100 ul of standard was added to the twelve tubes 
labeled for assay of the standard. 
4. 100 ul of sample was added to the remaining tubes. 
5. 100 ul of the tracer was added to all tubes. 
6. 100 ul of antiserum was added to each tube. 
7. Each tube was vortexed and refrigerated for twenty 
to twenty-four hours. 
8. 500 ul of magnetic goat anti-rabbit was added to 
each tube, except for the two total count tubes. 
9. Tubes were incubated for fifteen to twenty minutes 
at room temperature. 
10. With the exception of the total count tubes, each 
tube was centrifuged at 3000 rpm at 4 C for twenty 
minutes. 
11. Supernatant was decanted from each tube, except for 
total count tubes, and discarded as radioactive 
waste. 
12. Tubes were gently blotted on a plastic lined paper 
towel to remove remaining supernatant. 
13. Concentration of radioactivity present in each tube 
was counted in a gamma counter. 
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Thromboxane A2 concentrations were adjusted for exercise-
induced alterations in platelet count. Both PGI2 and TXA2 
were adjusted for alterations in hemoconcentration. The 
PGI2/TXA2 ratio was computed by dividing the plasma 
concentration of PGI2 by the adjusted plasma concentration 
of TXA2. 
Lipid Profile Assessment 
Serum total cholesterol, HDL, and triglycerides were 
determined by enzymatic procedures employed at Moses Cone 
Memorial Hospital in Greensboro, North Carolina. Plasma LDL 
was estimated by Moses Cone Memorial Hospital from the total 
cholesterol and triglyceride values. 
Nutritional Assessment 
Food records were analyzed first with Nutritionist III 
(N-Squared Computing, 1985) to estimate the average daily 
intake of linoleic acid, saturated fat and polyunsaturated 
fat. When Nutritionist III provided insufficient fat 
composition data, Food Values of Portions Commonly Used (Jean 
A. T. Pennington, 1989), was used to further estimate 
linoleic acid, saturated fat and polyunsaturated fat intake. 
Statistical Analysis 
In order to determine if there were statistically 
significant differences between V02max, sub-maximal exercise 
V02's and exercise intensity when expressed as a percentage 
of V02max the values from the two different age groups were 
compared using t-test. 
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The effects of age and exercise PGI2/TXA2 ratios, plasma 
PGI2» and plasma TXA2 in the two different age groups at 
rest, during exercise and during recovery were assessed with 
a 2 X 3 repeated measures analysis of variance. The Geisser-
Greenhouse correction factor was used to adjust the degrees 
of freedom for the F-test (Glass & Hopkins, 1984). When 
significant main effects were found, separate pairwise 
comparisons were made using Tukey's multiple comparison 
technique. 
The effect of dietary linoleic acid, P/S ratio, and serum 
HDL and LDL concentrations on the PGI2/TXA2 ratios, plasma 
PGI2, and plasma TXA2 were examined as follows: a separate 
2x3 repeated measures analysis of covariance was conducted 
using each of the above variables (i.e. dietary linoleic 
acid, P/S ratio, plasma HDL and plasma LDL) as covariates. 
Subject's with PGI2/TXA2 ratios more than two standard 
deviations beyond the group mean were removed from the 
analysis. Statistical significance was set at the 0.05 
probability level. 
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CHAPTER IV 
RESULTS 
Treatment of Individual Data 
Twenty subjects, ten young men (25 to 30 years old) and 
ten older men (50 to 62 years old), participated in the 
present study. Data from two subjects, one young man and one 
older man, were not included in the analysis. These data 
were removed because one PGI2/TXA2 ratio for each subject was 
more than two standard deviations beyond group means; and, 
these ratios were regarded physiologically implausible when 
compared to other ratios. 
Exercise Characteristics 
Assessment of the exercise data by the t-test procedure 
indicated that nine young men (27.8 + 0.8 years old) and nine 
older men (55.4 + 1.3), differed on V02max (p < 0.01) and 
highest heart rate achieved during the maximal exercise test 
(p < 0.001). Mean maximal heart rates were 101.4% and 104.0% 
of the age predicted maximal heart rates for the young and 
older groups, respectively. The V02's for the older men 
during the sub-maximal exercise session were lower than the 
younger men at approximately five (p < 0.001) and twenty 
minutes (p < 0.05) of exercise. However, V02's during sub-
maximal exercise, when expressed as a percentage of V02max, 
did not differ significantly between the two groups (Table 
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4). Body weights between the two groups were significantly 
different (p < 0.05). The mean body weight for the young men 
was 153.2 + 6.4 lb (69.6 + 2.8 kg) and 180.2 + 7.1 lb (81.9 
+ 3.2 kg) for the older men. 
Table 4. 
Exercise Characteristics 
HRmaxa V02max V02 VO2 %V02max %V02max 
Group (bpm) (ml/kg/min) 5 min 20 min 5 min 20 min 
Young 
Adult 
194.9** 
± 2.4 
53.4* 
± 2.8 
36.9* 
±1.4 
39.1** 
±1.7 
69 . 6  
± 1.8 
73.4 
± 0.8 
Older 
Adult 
171.2** 
± 2.9 
40.1* 
± 2.5 
28.2* 
±2.1 
28 J** 
±1.5 
69.7 
± 2.1 
74.0 
± 1.2 
Between group differences: *(p < .01); **(p < .001). 
aHighest heart rate achieved during maximal exercise test. 
PGI2/TXA2 Ratios 
Analysis of variance indicated that age had a significant 
ain effect on PGI2/TXA2 ratios (P = 5.92; p = 0.027). No 
significant differences in PGI2/TXA2 due to the main effect 
of exercise were found. 
Resting PGI2/TXA2 ratios were 7.44 + 1.42 for the young 
men and 5.90 + 0.99 for the older men (Figure 2). The mean 
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Figure 2. 
EFFECT OF AGE AND EXERCISE 
ON PGI2/TXA2 RATIOS 
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Observation Time 
resting ratio for the young group was 26.0% higher than the 
resting ratio for the older group; the difference was not 
significant. The mean ratio for the young men immediately 
following exercise increased 25.4% to 9.33 + 2.69; and, the 
mean ratio for the older men increased 10.3% to 6.51 + 1.14. 
These increases were not significant when compared to resting 
values. The exercise ratio for the young group was 43.3% 
greater than the exercise ratio for the older group; but, the 
difference was not significant. Thirty minutes following 
exercise the older men's ratio was 3.69 + .47, which was 
37.5% below their resting ratio. The young men's recovery 
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ratio was 6.83 + .57# or 8.2% below their resting ratio. The 
exercise values did not differ significantly from rest. The 
young group's recovery ratio was 85.2% greater than the older 
group's, although the difference statistically significant. 
PGI2 Concentrations 
Analysis of variance indicated that neither age (F = 
0.03; p = 0.857) nor exercise (F = 0.43; p = 0.654) had any 
main effect on plasma PGI2 (Figure 3). Resting 
concentrations of PGI2 were 355.56 + 82.38 pg/ml and 412.89 
+ 85.40 pg/ml for the young and older men, respectively. 
Figure 3. 
EFFECT OF AGE AND ACUTE EXERCISE ON PGI2 
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Immediately after exercise PGI2 concentrations were 389.05 
+ 47.01 pg/ml for the young group and 372.44 + 79.80 pg/ml 
for the older group. Thirty minutes following exercise PGI2 
concentrations were 349.57 + 29.48 pg/ml and 342.85 + 42.03 
pg/ml for the young and older men, respectively. No 
significant age group or exercise-induced differences were 
found for PGI2/ concentrations. 
TXA2 Concentrations 
Analysis of variance indicated that age had a significant 
main effect on plasma TXA2 (F = 4.52; p = 0.049). No 
significant differences in concentrations of TXA2 due to the 
main effect of exercise were found (P = 0.58; p = 0.565). 
Resting TXA2 concentrations were 53.33 + 9.62 pg/ml and 
79.00 + 18.15 pg/ml for the young and older groups, 
respectively (Figure 4). These values were not significantly 
different, although the TXA2 concentrations found in the 
older men was- approximately forty-eight percent higher than 
the young men's values. Immediately following thirty minutes 
of exercise circulating concentrations of TXA2 were 60.29 + 
15.94 pg/ml for the young group and 72.79 + 13.71 pg/ml for 
the older group. These values were not significantly 
different from each other, nor were they significantly 
different from resting values. 
Thirty minutes following exercise the TXA2 concentration 
for the young men was 54.44 + 6.19 pg/ml. The TXA2 
concentration for the older men was 101.71 + 16.38 pg/ml, or 
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nearly two-fold greater than the value for the young men, 
although these values were not significantly different. No 
significant differences in TXA2 concentrations due to the 
effect of exercise were found within either age group. 
Exercise appears to have a dramatic influence on TXA2 in 
older men when concentrations are measured thirty minutes 
following exercise. 
Figure 4. 
EFFECT OF AGE AND ACUTE EXERCISE ON TXA2 
Young Men 
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Res t  Exe rc i s e  Recove ry  
Observation Time 
Lipid Profiles 
Group values for total cholesterol were significantly 
different (p < 0.05) when analyzed by t-test procedures. The 
older men had higher total cholesterol values when compared 
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to the younger men. Values for HDL, LDL and triglycerides 
were not different at the 0.05 alpha level (Table 5). The 
older group's LDL values were eighteen percent higher than 
the younger group, although the difference was not 
significant. 
Table 5. 
Lipid Profiles 
Total 
Cholesterol HDL LDL Triglycerides 
Group (mg/dl) (mg/dl) (mg/dl) (mg/dl) 
Young 176.8* 52.2 108.3 81.8 
Adult ± 8.7 ± 5.6 ± 5.9 ± 14.7 
Older 218.1* 52.6 132.0 216.2 
Adult ±12.6 ± 4.0 ±12.6 ± 209.2 
Between group differences: *(p < .05). 
HDL, LDL, and Total Cholesterol as Covariates 
High density lipoprotein was not used as a covariate 
since there was not a significant difference between group 
values. The age group-related main effect differences 
between PGI2/TXA2 ratios for each group were eliminated when 
LDL was used as a covariate. The p-value for the effect of 
the between subject factor, group, on PGI2/TXA2 ratios was 
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0.101 (F = 3.08); and, the p-value for the regression factor, 
LDL, was 0.115 (F = 2.83). The age group-related main effect 
differences between TXA2 concentrations for each group were 
eliminated when LDL was used as a covariate. The p-value for 
the effect of group on TXAj concentrations was 0.162 (F = 
2.18); and the p-value for LDL was 0.640 (F =0.23). 
Total cholesterol was used as a covariate, since a 
significant difference between the young and older men's 
values was obtained. The age group-related main effect 
differences between both PGIJ/TXAJ ratios and TXA2 
concentrations were eliminated when total cholesterol was 
used as a covariate. The p-value for the effect of the 
between subject factor, group, on PGIJ/TXAJ ratios was 0.117 
(F = 2.00); whereas, the p-value for the regression factor, 
LDL, was 0.290 (F = 1.20). The p-value for the effect of 
group on TXA2 concentrations was 0.144 (F = 2.37); and, the 
p-value for LDL was 0.764 (F = 0.09). 
Dietary Characteristics 
Group values for mean daily intake of K-calories and 
grams of fat were not significantly different. Mean daily 
intake of linoleic acid, when expressed as a percentage of 
mean daily total caloric intake was not significantly 
different between the two groups. 
Group values for P/S ratios approached a statistically 
significant difference (p = 0.09). This tendency was 
characterized by a significant difference in the mean daily 
intake of polyunsaturated fat in grains (p < 0.05). Daily 
intake of saturated fat was not different (Table 6). 
Table 6. 
Dietary Characteristics 
Mean Polyc Sat^ Linoleice 
Daily Fat*> Fat Fat P/S Acid 
Group Kcala (g) (g) (g) Ratio (% Kcal) 
Young 2611.6 86.7 38.42* 28.66 1.66 5.74 
Adult £ 251.2 ±, 10.1 ±_ 4.62 i 5.26 £ .36 £ .07 
Older 2404.0 83.7 25.95* 26.33 1.00 4.98 
Adult ± 214.5 ± 10.2 ± 3.11 ± 2.53 ± .11 ± .02 
Between group differences; *(p < 0.05). 
aMean daily intake of Calories. 
bMean daily intake of fat (grams) 
€Mean daily intake of polyunsaturated fat (grams). 
'Mean daily intake of saturated fat (grams). 
eMean daily intake of linoleic acid (grams), expressed as a 
percentage of mean daily intake of Calories. 
Linoleic Acid, P/S Ratios, and Polyunsaturated 
Fat as Covariates 
Linoleic acid was not used as a covariate since there was 
not a significant difference between group values. The age 
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group-related main effect difference between PGI2/TXA2 ratios 
for each group was still present when P/S ratios were used 
as covariates. The p-value for the effect of the between 
subject factor, group, on PGI2/TXA2 ratios was 0.050 (F = 
4.54); and, the p-value for the regression factor, P/S fat 
ratios, was 0.963 (F = 0.00). The age group-related main 
effect differences between TXA2 concentrations for each group 
were eliminated when P/S ratios were used as covariates. The 
p-value for the effect of group on TXA2 concentrations was 
0.087 (F = 3.36); and the p-value for P/S ratios was 0.913 
(F = 0.01). 
Mean daily intake of polyunsaturated fat in grams was 
used as a covariate, since a significant difference between 
the young and older group's values was found. The age group-
related main effect difference between PGI2/TXA2 ratios for 
each group remained when polyunsaturated fat was used as a 
covariate. The addition of the polyunsaturated fat did not 
make a significant contribution to the analysis as the error 
term actually increased from 14.23 to 14.71. The p-value for 
the effect of the between subject factor, group, on PGI2/TXA2 
ratios was 0.030 (F = 5.75); and, the p-value for the 
regression factor, polyunsaturated fat, was 0.497 (F = 0.48). 
The age group-related main effect difference between TXA2 
concentrations for each group was eliminated when 
polyunsaturated fat was used as a covariate. The p-value for 
the effect of group on TXA2 concentrations was 0.070 (F = 
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3.80); and the p-value for polyunsaturated fat was 0.716 (F 
= 0.14). 
Summary of the Results 
The heart rate data suggest that both groups achieved 
maximal exercise capacities during the maximal exercise test. 
The relative intensities maintained during the sub-maximal 
exercise test were, the same for both groups, although the 
absolute intensities were significantly different. 
Resting and immediate post-exercise PGI2/TXA2 ratios were 
not different between the two groups. There was 
approximately a two-fold difference between the young and 
older group's PGI2/TXA2 ratios thirty minutes following 
exercise, although the difference was not statistically 
significant. The apparent difference was characterized by 
a 28.7% increase in TXA2 above resting concentrations in the 
older group as compared to a essentially no change in the 
young group thirty minutes after exercise. 
Total cholesterol and dietary intake of polyunsaturated 
fat were significantly different between the two groups. 
Linoleic acid intake, expressed as a percentage of total 
caloric intake, and serum LDL between the two groups 
approached statistically significant differences. None of 
the lipoprotein or dietary characteristics had a significant 
impact on the statistical analysis when they were used as 
covariates. 
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CHAPTER V 
DISCUSSION 
Clinical manifestations of coronary heart disease may be 
initiated by platelet aggregation resulting from platelet 
contact with damaged endothelial tissue (Daviesr & Thomas, 
1984; Freeman, Williams, Chisholm, & Armstrong, 1989). 
Monocada and Vane (1979), suggested that the ratio between 
circulating concentrations of PGI2 and TXA2 has an important 
role in determining the extent of platelet aggregation; and, 
the lower the PGI2/TXA2 ratio the greater the predisposition 
towards platelet aggregation. Age, exercise, and diet may 
have an indirect role in platelet aggregation as consequence 
of their influence on PGI2/TXA2 ratios. This study was 
intended to elucidate the combined effects of age and 
exercise on PGI2/TXA2 ratios. Dietary and lipid profile 
differences existing between the two groups were controlled 
for statistically. 
Exercise Characteristics 
The statistically significant difference between maximal 
heart rates reported for the young and older men resulted in 
rejection of the hypothesis that there would be no difference 
between the groups. Mean maximal heart rates were 101.4% and 
104.0% of the age predicted maximal heart rate for the young 
and older men, respectively. The highest heart rates 
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achieved during the maximal exercise test were within four 
percent of age predicted values for each group, suggesting 
that the subjects achieved maximal exercise capacities during 
this test. 
Mean V02max's for the two groups were significantly 
different. The hypothesis that the two groups would not have 
different VOjmax's was rejected. There was not a significant 
difference between the groups when sub-maximal exercise 
intensity was expressed as a percentage of the maximal 
exercise intensity. The hypothesis that the two age groups 
would not have different sub-maximal exercise intensitites 
was accepted. 
Mean VOjmax for the young men was 53.42 + 2.8 ml/kg/min, 
indicating that this group of subjects was in the 
"excellent" oxygen consumption category (Pollock, & Blair, 
1981). Individual VOjinax's for the young men ranged from 
"fair" (41.14 ml/kg/min) to "excellent" (66.80 ml/kg/min). 
Mean VC^max for the older men was 40.14 + 2.5 ml/kg/min, 
placing this group in the "very good" oxygen consumption 
category. Individual VC^max's for the older men ranged from 
"fair" (28.50 ml/kg/min) to "excellent" (52.30 ml/kg/min). 
The range of VC^max data (i.e. 26.66 and 23.80 ml/kg/min in 
the young and older men, respectively) within groups 
indicates that each group was somewhat heterogenous. The 
heterogeneity of the V02max data combined with the fact that 
significant correlations were found between V02max and 
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recovery PGI2/TXA2 ratios (r = .67; p = 0.001), V02max and 
resting TXA2 concentrations (r = -.44; p = 0.036), and V02max 
and recovery TXA2 concentrations (r = -.67; p = 0.001) 
suggest that aerobic fitness may influence PGI2/TXA2 ratios 
via plasma TXA2 concentrations. The V02max data was added 
as a covariate in the analysis of the effect of age and 
exercise on PGI2/TXA2 ratios and TXA2 concentrations since 
significant correlations were found to exist between these 
variables. Addition of the V02max data did not have a 
significant influence on the results. Several factors 
including the small sample size and a lack of accountability 
and control over the exercise training habits of subjects may 
have led to the low correlations found between the two 
groups. Exercise training status may correlate better with 
prostanoid concentrations, since V02max is not always a 
satisfactory indicator of exercise training. 
Rauramaa et al. (1984) reported that improvements in 
V02max following an eight week exercise training program were 
associated with increased PGI2 and decreased TXA2 
concentrations at rest. These researchers also reported that 
the increase in PGI2 was positively related to alterations 
in the HDL2 subfraction. Although Rauramaa et al. (1984) 
reported that LDL decreased significantly, they did not state 
if this reduction was significantly correlated with the 
decline in TXA2. 
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In contrast to the findings reported by Rauramaa et al. 
(1984)/ Symons (1984) found that increased V02max following 
exercise training was not associated with any change in 
resting prostanoid concentrations. Symons (1984) did not 
find a significant change in HDL following exercise training. 
In the present study, HDL concentrations were not 
significantly different between groups; and, HDL2 
subfractions were not measured. 
Neither Symons (1984) nor Rauramaa et al. (1984) 
investigated the effect of exercise training on prostanoid 
concentrations during or following an acute bout of exercise. 
Although data from the present investigation suggest that a 
significant negative correlation exist between aerobic 
capacity and TXA2 concentrations further research is needed 
to determine if this is just an association or a true cause 
and effect relationship. Additional research investigating 
the effects of exercise training on prostanoid concentrations 
appears to be warranted. 
Effect of Age and Exercise on PGI2/TXA2 Ratios 
Analysis of variance indicated that age had a significant 
main effect on PGI2/TXA2 ratios (p < 0.05). Thus, the 
hypothesis that age had no effect on PGI2/TXA2 ratios was 
rejected. No significant differences in PGI2/TXA2 due to the 
main effect of exercise were found; and, the hypothesis that 
exercise had no effect on PGI2/TXA2 ratios remained tenable. 
53 
Resting PGI2/TXA2 Ratios 
The presentation of PGI2/TXA2 ratio data by other 
researchers are limited. Mean data can be used to compute 
PGI2/TXA2 ratios, although such computations may provide 
erroneous data. For example, when the mean resting data for 
the young men in the present study were used to compute the 
PGI2/TXA2 ratio the value was 6.68. When individual data 
were used to compute ratios and the mean was calculated from 
these individual ratios the PGI2/TXA2 ratio was 7.44. For 
the purposes of this discussion PGI2/TXA2 ratios pertaining 
to other research will be calculated using mean data, unless 
the researchers provided individual data. 
Resting PGI2/TXA2 ratios were not significantly different 
between the two groups in the present study. Thus, the 
hypothesis that there would not be a significant difference 
between the two group's resting ratios was accepted. The 
mean PGI2/TXA2 ratio for the young men (7.44 + 1.42) was 
twenty-six percent higher than the mean ratio for the older 
men (5.90 + 0.99). A similar difference between two age 
groups was computed from the mean prostanoid data reported 
by Vericel et al. (1988). The PGI2/TXA2 ratio for their 
young group was 4.62; whereas, the ratio for their older 
group was 3.75. The PGI2/TXA2 ratio for their young group 
was twenty-three percent greater than the ratio for their 
older group. 
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The derived PGI2/TXA2 ratios in the study by Vericel et 
al. (1988) were characterized by elevated concentrations of 
both prostanoids in the older group. Only the PGI2 
concentrations, which were 63% higher in their older group, 
were significantly different between the two groups, although 
the TXA2 concentrations were two-fold greater in their older 
group. Data from the present study were similar, with plasma 
PGI2 16.2% higher and TXA2 concentrations 48.1% higher in the 
older group. 
Reilly and FitzGerald (1986) reported that both urinary 
concentrations of PGI2 and TXA2 were higher in older adults 
when compared to young adults. These findings are in 
agreement with data from the present study and with the 
results reported by Vericel et al. (1988); however, when the 
mean values presented by Reilly and FitzGerald are used to 
compute PGI2/TXA2 ratios the older group appears to have the 
more favorable ratio. The PGI2/TXA2 ratios were .796 and 
.883 for the young and older adults, respectively. 
The report by Vericel et al. (1988) and the present study 
suggest that age-related alterations in PGI2/TXA2 ratios may 
predispose older adults to platelet aggregation under resting 
conditions; whereas, Reilly and FitzGerald (1986) reported 
that PGI2/TXA2 ratios were only slightly different between 
the two age groups. Age-related alterations were 
characterized by increases in both PGI2 and TXA2 
concentrations in each of the studies reviewed. Thus, one 
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might conclude that the increased risk of platelet 
aggregation associated with an age-related increase in TXA2 
is attenuated by a concomitant increase in PGI2. 
Exercise and Recovery PGI0/TXA2 Ratios 
There was not a significant difference between the two 
group's PGI2/TXA2 ratios immediately following exercise, 
although the ratio for the young men was 43.3% greater than 
the ratio for the older men. The hypothesis that there would 
not be a significant difference between the young and older 
men's ratios immediately following exercise was accepted. 
The large degree of variability among the young men's 
PGI2/TXA2 ratios immediately after exercise and the small 
sample size may have contributed to the lack of significance. 
Following exercise the PGI2/TXA2 ratios for each group 
tended to rise when compared to the resting values. The 
increases above resting values were approximately twenty-
five percent for the young men and ten percent for the older 
men. These data suggest that, when compared to resting 
values, neither group was more predisposed to platelet 
aggregation immediately after exercise. 
Metha et al. (1983) found a greater than two-fold 
increase in PGI2/TXA2 ratios immediately following exercise. 
These exercise-induced alterations were characterized by 
increases in both plasma PGI2 and TXA2 concentrations. In 
the present study, PGI2/TXA2 ratios in the young group tended 
to increase immediately after exercise; and, the increase was 
56 
marked by a slight increase in both plasma PGI2 and TXA2. 
The results reported by Metha et al. (1983) are consistent 
with the data from the young group involved in the present 
study. 
Taniguchi et al. (1984) reported contrasting results. 
These researchers found that PGI2/TXA2 ratios declined by 
approximately 40% immediately following twelve minutes of 
treadmill exercise (Taniguchi, Furui, Yamauchi, & Sotobata, 
1984). The exercise-induced changes reported by Taniguchi 
et al. (1984) were characterized by an 11% decline in PGI2 
and a 48% increase in TXA2. In contrast, during the last 
minute of exercise both PGI2 and TXA2 concentrations were 
within one percent of resting values (Taniguchi, Furui, 
Yamauchi, & Sotobata, 1984). The inconsistencies among the 
data presented by Taniguchi et al. (1984) may indicate that 
a large degree of experimental error was present in their 
study. 
In the present study, the PGI2/TXA2 ratio for the young 
men thirty minutes following exercise was similar to their 
resting ratio. Both PGI2 and TXA2 returned to near resting 
levels for the young group at thirty minutes recovery. In 
the older men, the PGI2/TXA2 ratio dropped 37.5% below the 
resting value. This change was characterized by a 28.7% 
increase in TXA2 concentrations above resting concentrations. 
The ratio in the younger group was approximately two-fold 
greater than the ratio for the older group; however, the 
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difference between the two group's ratios were not 
statistically significant. Thus, the hypothesis that there 
was not a significant difference between recovery ratios for 
the young and older men was accepted. The large degree of 
variability associated with the young men's immediate post-
exercise data may have contributed to the fact that a 
significant between group difference was not found thirty 
minutes following exercise. 
These data suggest that thirty minutes after exercise, 
older men may be more predisposed to platelet aggregation 
than young men. The fact that the older group's PGI2/TXA2 
ratios thirty minutes post-exercise were lower than their 
resting ratios provides additional evidence that some older 
men may be more susceptible to platelet aggregation after 
exercise. 
Discussion of the potential underlying mechanisms 
associated with the apparent age related differences in 
PGI2/TXA2 ratios is presented later in this chapter. 
However, one observation made while comparing the results of 
the present study with another investigation will be 
presented here. 
Metha et al. (1983) investigated whether or not PGI2 and 
TXA2 concentrations were different at rest and following 
exercise in persons with known coronary heart disease as 
compared to apparently healthy individuals. The PGI2/TXA2 
ratios computed from mean data indicated that fifteen to 
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thirty minutes following exercise the apparently healthy 
subject's ratios returned to near resting levels; whereas, 
the ratios for the subjects with coronary heart disease fell 
below resting levels (Metha, Metha, & Horalek, 1983). The 
exercise-induced alterations in PGIJ/TXAJ ratios for some of 
the older subjects in the present study may be similar to the 
responses exhibited by persons with coronary artery disease, 
suggesting that some older persons in the present study may 
have coronary artery disease or manifest some of the 
mechanisms leading to coronary artery disease. This 
possibility cannot be completely ruled out, although careful 
subject screening was employed to eliminate potential 
subjects with this disorder. 
Effect of Age and Exercise on PGI2 
Analysis of variance indicated that neither age nor 
exercise had any main effect on plasma PG^* These results 
supported the null hypothesis. 
Resting PGI^ Concentrations 
In the present study resting concentrations of PGI2 
between the two age groups were not significantly different. 
This finding is consistent with results reported by Hanley 
and May (1985); but, it does not concur with reports by 
Reilly and Fitzgerald (1986) or vericel et al. (1988). 
Hanley and Nay (1986) reported that there was no significant 
relationship between age and PGI2 synthesis in saphenous 
venous tissue removed from men and women treated for varicose 
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veins. The researchers analyzed the data for men and women 
separately. There is a lack of evidence indicating whether 
or not vascular changes associated with varicose veins alters 
prostanoid synthesis; and, data collected from smokers was 
included in the analysis. Several researchers have reported 
that nicotine and smoking inhibits the synthesis of PGI2 
(Pittilo, Mackie, Rowles, Machin, & Woolfr 1982; Sonnenfeld, 
& Wennmalm, 1980; Wennmalm, 1980). 
Reilly and FitzGerald (1986) reported that resting 
urinary PGI2 concentrations were higher among adults 50 to 
88 years old when compared to adults 21 to 39 years old. 
Reilly and FitzGerald (1986) did not measure circulating 
concentrations of PGI2; but, under resting conditions, 
urinary concentrations of PGI2 paralleled circulating PGI2 
concentrations (Vericel et al., 1988). 
Vericel et al. (1988) reported that both urinary and 
serum PGI2 concentrations at rest were higher in 78 to 94 
year old adults when compared to 25 to 35 year old adults. 
Serum concentrations of PGI2 were approximately two-fold 
higher in the older adults. In the present study, resting 
plasma PGI2 concentrations in the older men were 
approximately sixteen percent greater than PGI2 
concentrations found in the young men. 
One factor that may have contributed to the contrasting 
results between the present study and other studies is that 
the age range between the young and old groups was greater 
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in the other studies. The ranges were approximately 56 years 
in the study by Vericel et al. (1988), 39 years in the study 
by Reilly and FitzGerald (1986), and 28 years in the present 
study. Vericel et al. (1988) reported finding a significant 
difference between the two age groups. Reilly and Fitzgerald 
(1986) did not find a significant difference? but, urinary 
PGI2 concentrations in the older group were 62% greater than 
in the younger group. These reports suggest that age-
related increases in PGI2 may not obtain statistically 
significant levels until individuals reach 65 to 70 years 
old. 
Another factor that might have contributed to the 
differences between the present study and the study by 
Vericel et al. (1988) is that group activity and fitness 
levels may have been different between these studies. 
Vericel et al. (1988) did not provide any information 
regarding the fitness or activity levels of their subjects. 
In the present study there were similar numbers of training 
and non-training individuals in each group; however, subjects 
represented a wide range of aerobic fitness categories. 
Future research should attempt to account for the effect 
exercise training may have on prostanoid concentrations since 
Rauramaa et al. (1984) reported that exercise training may 
lead to significant alterations in PG^. 
Both the lack of an age-related difference in resting 
PGI2 concentrations found in the present study and the 
61 
existence of age-related increases reported by other 
researchers (Vericel et al., 1988) seem to contradict data 
gathered from studies conducted in vitro. Researchers have 
consistently reported that fresh aortic tissue samples from 
older animals (i.e. rats and swine) release significantly 
less PGI2 than samples from younger, mature animals (Chang, 
Murota, & Nakao, 1980; Chang, & Tai, 1983; Giani, Masi, & 
Galli, 1985; Kent, Kitchell, Shand, & Whorton, 1981; Menconi, 
Taylor, Martin, & Polgar, 1987). The lack of agreement 
between these two bodies of literature may be related to the 
fact that PGI2 synthesis is influenced by many substances 
found in the circulation. Some of these substances include: 
arachidonic acid, adenosine diphosphate, collagen, bradykinin 
(Menconi, Taylor, Martin & Polgar, 1987), HDL, LDL (Beitz, 
& Forster, 1980), and the essential fatty acids (DuPont, 
1987). Beitz and Forster (198) have shown that PGI2 
synthesis from PGH2, a component of the arachidonic acid 
cascade, is enhanced in the presence of HDL and inhibited by 
LDL. Research conducted in vitro may limit the tissue 
exposure to one or more of the above substances. Further 
investigation of PGI2 synthesis from animal tissues bathed 
in different mediums is needed. Tissue samples taken from 
animals following acute or chronic exercise may also provide 
valuable information regarding the effects of exercise on 
PGI2 synthesis. 
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Exercise and Recovery PGIQ Concentrations 
No significant changes in plasma PGI2 concentrations 
resulting from exercise were found in the present study. 
These results concur with findings reported by several other 
researchers (Carter, Ready, Singhroy, Duta, & Gerrard, 1989; 
Taniguchi, Furui, Yamauchi, & Sotobata, 1984; Todd, Goldfarb, 
& Boyer, 1990). Other researchers have reported that PGI2 
concentrations increase as a result of exercise (Demers, 
Harrison, Halbert, & Santen, 1981; Metha, Metha, & Horalek, 
1983; Piret et al., 1990; Viinikka, Vuori, & Ylikorkala, 
1984). 
Closer investigation of the exercise protocols utilized 
in other studies suggest that alterations in PGI2 
concentrations may be influenced by exercise intensity and 
duration. Studies associated with no significant changes in 
PGI2 concentrations involved sub-maximal exercise (Carter, 
Ready, Singhroy, Duta, & Gerrard, 1989; Taniguchi, Furui, 
Yamauchi, & Sotobata, 1984; Todd, Goldfarb, & Boyer, 1990). 
Significant alterations in PGI2 concentrations occurred when 
subjects exercised at maximal intensity (Metha, Metha, & 
Horalek, 1983; Piret et al., 1990). Subjects in the study 
by Viinikka et al. (1984), exercised to exhaustion; but, the 
only significant alteration in PGI2 was found after seven 
minutes of exercise. Immediately following exercise PGI2 
concentrations returned to near resting concentrations. 
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The impact of long duration exercise on PGI2 
concentrations remains unclear. Demers et al. (1981), 
reported that plasma PGI2 concentrations were significantly 
elevated following a marathon run; whereas, Carter et al. 
(1989) found no change after a 21 or 42 kilometer run. One 
difference in these two studies was that Demers et al. (1981) 
did not expose fresh whole blood samples to a prostanoid 
inhibitor. 
Sub-maximal exercise, thirty minutes or less in duration, 
has not been associated with significant alterations in PGI2 
concentrations (Carter, Ready, Singhroy, Duta, & Gerrard, 
1989; Taniguchi, Furui, Yamauchi, & Sotobata, 1984; Todd, 
Goldfarb, & Boyer, 1990). The results from this study are 
consistent with the results from previous investigations. 
No significant age-related differences in PGI2 
concentrations were found immediately following exercise or 
thirty minutes after exercise. Other research involving the 
effects of age on PGI2 during or following exercise were not 
found. Among the studies investigating the effects of 
exercise on PGI2 concentrations mean age groups ranged from 
22.2 + 0.06 years old (Piret et al., 1990) to 50 + 4.0 years 
old (Metha, Metha, & Horalek, 1983). These researchers 
reported similar results, with PGI2 concentrations 
significantly increasing following exercise (Piret et al., 
1990; Metha, Metha, & Horalek, 1983). The results of the 
present study suggest that age has no influence on plasma 
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PGI2 concentrations immediately following thirty minutes of 
exercise at 70% to 75% of V02max or thirty minutes after 
exercise. The difference between the mean age for the two 
groups in this study was 27.6 years. Additional research 
investigating the effects of exercise on PGI2 concentrations 
between groups representing a wider age range is warranted, 
especially since other researchers have reported that resting 
PGI2 concentrations may differ between subjects from 
different age groups (Vericel, Croset, Sedivy, Courpron, 
Dechavanne, & LeGarde, 1988). 
Effect of Age and Exercise on TXA2 
Analysis of variance indicated that age had a significant 
main effect on plasma TXA2 (p < 0.05). The null hypothesis 
that age has no effect on TXA2 concentrations was rejected. 
No significant differences in concentrations of TXA2 due to 
the main effect of exercise were found. Thus, the null 
hypothesis remained tenable. 
Resting TXAQ Concentrations 
In the present study, resting concentrations of TXA2 
between the two age groups were not significantly different. 
The hypothesis that resting plasma TXA2 would not be 
different between the two age groups was accepted. This 
finding is consistent with results reported by Vericel et al. 
(1988); but, it does not concur with data reported by Reilly 
and FitzGerald (1986). Reilly and FitzGerald noted that 
resting urinary TXA2 concentrations were 46.7% higher in 
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adults 50 to 88 years old when compared to adults 21 to 39 
years old (p < 0.005). Vericel et al. (1988) reported that 
urinary TXA2 concentrations at rest were two-fold higher in 
78 to 94 year old adults when compared with 25 to 35 year old 
adults; but, the difference was not significant. Plasma TXA2 
was 48% greater in the older men, in the present study. 
In contrast, Vericel et al. (1988) reported that serum 
concentrations of TXA2 were two-fold greater in young adults 
when compared to older adults. The difference was 
statistically significant (p < 0.05). Reilly and FitzGerald 
(1986) found that serum TXA2 was twelve percent higher in 
young adults. The apparently contrasting results associated 
with the analysis of serum TXA2 may be due to platelet 
exposure to the high concentrations of thrombin released when 
whole blood is allowed to clot. Blood clotting is necessary 
for serum formation. Vericel et al. (1988) suggested that 
the availability of AA is depressed in older adults; and, 
when platelets from older subjects are exposed to high 
concentrations of thrombin there is less AA available for the 
formation of TXA2. This hypothesis led these researchers to 
reason that urinary concentrations of TXA2 were more 
representative of "basal" circulating concentrations than 
serum TXA2. Vericel et al. (1988) also demonstrated that 
platelet TXA2 formation was significantly greater in older 
adults following stimulation with low concentrations of 
thrombin. The 48% age-related difference in plasma 
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concentrations of TXA2 found in the present study, which was 
similar to those reported by both Vericel et al. (1988) and 
Reilly and FitzGerald (1986), might be expected since plasma 
is extracted from whole blood without activation of the 
clotting mechanisms. 
In vitro investigations of TXA2 release following 
stimulation by AA (Chang, & Tai, 1983) and collagen (Giani, 
Masi, & Galli, 1985) indicate that platelets from older rats 
produce significantly more TXA2 than younger rats. The 
results from these studies add additional support to the 
research involving human subjects. 
The research by Reilly and FitzGerald (1986) suggest that 
older adults may have higher resting concentrations of TXA2. 
Significant age-related differences were not found in the 
present study or by Vericel et al. (1988); however, the 
direction and the magnitude of difference found in these 
studies are in agreement with Reilly and FitzGerald's 
findings. The results from research involving animal models 
concur with the research conducted on humans. 
Exercise and Recovery TXA2 Concentrations 
Concentrations of TXA2 immediately following thirty 
minutes of exercise were similar for both the young and older 
men. The hypothesis that plasma TXA2 would not be 
significantly different between the young and older men 
remained tenable. Other research pertaining to prostanoid 
concentrations in different age groups immediately following 
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exercise was not found; and, other groups studied consisted 
primarily of younger subjects. 
Plasma TXA2 immediately after exercise was not 
significantly different from resting concentrations. Other 
researchers have reported similar results (Carter, Ready, 
Singhroy, Duta, & Gerrard, 1989; Metha, Metha, & Horalek, 
1983; Taniguchi, Furui, Yamauchi, & Sotobata, 1984; Todd, 
Goldfarb, & Boyer, 1990; Viinikka, Vuori, & Ylikorkala, 
1984). 
Carter et al. (1989) found that fifteen minutes of 
cycling at thirty percent of V02max was associated with a 
significant increase in TXA2 concentrations. This response 
occurred only following mild exercise, and not in response 
to more intense exercise (Carter, Ready, Singhroy, Duta, and 
Gerrard, 1989). One potential problem with the study by 
Carter et al. (1989) pertains to the fact that an intravenous 
catheter was used to collect blood samples during the mild 
exercise and not during the more vigorous exercise. 
Furthermore, Todd et al. (1990) reported that plasma TXA2 
concentrations tended to be positively associated with 
exercise intensity in a study in which a catheter was used. 
A catheter may cause damage to the endothelial lining during 
exercise; and, the damage may be more pronounced at the 
higher exercise intensities, which may be associated with 
more vigorous movements. This hypothesis is partly supported 
by the research conducted by Mant et al. (1984). These 
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researchers reported that evidence of platelet activation 
(i.e. platelet factor four and beta thromboglobulin 
formation) was greater when blood samples from exercising 
subjects were collected from an indwelling catheter as 
opposed to venipuncture techniques (Mant, Kappagoda, & 
Quinlan, 1984). Platelet activation may be stimulated by 
TXA2 formation. 
The absence of exercise-induced alterations in TXA2 
concentrations immediately following exercise appear to be 
a consistent finding among the different research studies. 
Evidence indicating that circulating concentrations of TXA2 
may be increased during exercise is weak since indwelling 
catheters were used to collect data for these studies. 
Plasma TXA2 concentrations in the young men thirty 
minutes following exercise were similar to resting 
concentrations. However, TXA2 concentrations among the older 
men were approximately twenty-nine percent higher when 
compared to their resting values; and, these concentrations 
were nearly two-fold greater than those found in the young 
men at the same observation time. The difference between the 
recovery values for the young and older men was not 
statistically significant; thus, the hypothesis that plasma 
TXA2 would not be significantly different between the two age 
groups was accepted. These data suggest that in the absence 
of changes in PGI2 older men may be more predisposed to 
platelet aggregation thirty minutes after exercise than at 
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rest or during exercise. The large degree of variability at 
each observation time indicates that this may not occur in 
all older subjects. This finding is unique to the present 
study as no other research pertaining to the effects of age 
and exercise on prostanoid concentrations was found. 
The older men tended to display increases in TXA2 
concentrations thirty minutes after exercise, which may be 
partly related to exercise-induced increases in various 
agents known to stimulate platelet release of TXA2. Vericel 
et al. (1988) demonstrated that platelet aggregation was 
greater in older adults when platelets were exposed to low 
concentrations of collagen (0.25 ug/ml) and epinephrine (2 
uM). Both of these substances may induce platelet 
aggregation by stimulating TXA2 release from platelets. The 
increased platelet aggregation found in their study was 
associated with increased TXA2 production (Vericel et al., 
1988). Furthermore, Hendra et al. (1988) reported that 
concentrations of both collagen and epinephrine needed to 
stimulate platelet aggregation following exercise were lower 
when compared to the concentrations needed prior to exercise. 
These two investigations indicate that older persons may be 
more predisposed to TXA2 formation following platelet 
exposure to epinephrine and collagen and that platelet 
sensitivity to these substances increases with exercise. 
Numerous studies have reported that epinephrine 
concentrations increase with exercise (Christensen, & Galbo, 
70 
1983). One might hypothesize that the increase in 
epinephrine during exercise may stimulate a greater increase 
in TXA2 concentrations in older men when compared to young 
men. One problem with this hypothesis is that the increased 
TXA2 concentrations were found thirty minutes following the 
completion of exercise, not immediately after exercise. 
Epinephrine concentrations return to pre-exercise 
concentrations within five to ten minutes following the 
cessation of exercise (Lehmann, Kapp, Himmelsbach, & Keul, 
1982; Taniguchi, Furui, Yamauchi, & Sotobata, 1984). One 
might expect that TXA2 concentrations would be elevated 
immediately following exercise as opposed to thirty minutes 
following exercise, unless other agents stimulate increases 
following exercise. Additionally, TXA2 release initiated by 
epinephrine may be perpetuated by other agents. For example, 
TXA2 may stimulate the release of additional TXA2. This 
feed-forward mechanism may sustain increased release of TXA2 
after epinephrine concentrations have subsided. Results from 
the investigation conducted by Taniguchi et al. (1984) 
support this hypothesis. These researchers found that both 
epinephrine and TXA2 concentrations immediately following 
exercise were elevated above resting concentrations. By six 
minutes after the cessation of exercise epinephrine had 
subsided to near resting concentrations, while TXA2 remained 
elevated. Thirty minutes following exercise TXA2 
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concentrations were still above resting values (Taniguchi, 
Furui, Yamauchi, & Sotobata, 1984). 
No reports regarding the effect of acute exercise on 
circulating concentrations of collagen or platelet contact 
with collagenous tissue were found; however, it is plausible 
that contact between collagen and platelets may increase with 
exercise and that this interaction may continue after the 
cessation of exercise. Evidence indicates that older adults 
may be more susceptible to collagen-platelet interaction due 
to age-related increases in both collagen content within the 
vascular tissue (Barnes, 1988) and the number of collagen 
cross linkages (Nimni & Harkness, 1988). 
The prevalence of both atherosclerosis and 
arteriosclerosis increases with age. Atherosclerosis is 
associated with the proliferation of platelets and other 
substances into the intimal layer of the vasculature. Upon 
proliferation into the vascular wall platelets release 
platelet derived growth factor which stimulates the growth 
of vascular tissue. This vascular repair mechanism provides 
a means for the development of plaque deposits when high 
concentrations of fat and cholesterol are present in the 
blood. When atherosclerotic plaque deposits are damaged, 
collagen fibers, which may be present in high concentrations 
within these plaque formations, come into contact with 
platelets (Barnes, 1985). 
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Arteriosclerosis is associated with a reduction in the 
elasticity of arterial tissue. The age-related loss of 
elasticity predisposes arterial linings to damage when 
capacitance demands suddenly change. For instance, when 
exercise is initiated and the demand for blood flow to the 
exercising muscles suddenly increases. Any resulting 
arterial damage may lead to increased contact between 
collagen and platelets (Guyton, 1986). 
In addition to plaque and vascular tissue damage 
associated with alterations in blood flow, exercise-induced 
mechanical stresses may cause damage to plaque formations and 
sclerotic arteries. One must recognize that there is little 
evidence supporting this and other hypotheses regarding 
exercise mediated contact between platelets and collagenous 
tissue. 
Circulating concentrations of TXAj immediately following 
thirty minutes of exercise were similar to resting values for 
both young and older men. No significant differences between 
the two groups were observed at this observation time. 
Plasma concentrations of TXA2 thirty minutes after exercise 
tended to be higher among the older men when compared to the 
younger men, although the difference was not statistically 
significant. Thromboxane A2 concentrations among the older 
group thirty minutes following exercise were twenty-nine 
percent greater than resting values. These data suggest that 
some older men may be more predisposed to platelet 
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aggregation following exercise when compared with younger 
men. The mechanisms mediating these apparent alterations in 
TXA2 are unclear. 
Lipid Profiles 
Total serum cholesterol in the older group was twenty-
three percent higher and significantly different from the 
young group. The use of total cholesterol as a constant 
covariate did not have a significant influence on the 
analyses of PGI2/TXA2 ratios and TXA2 concentrations. Thus, 
the hypothesis that total cholesterol would not influence the 
effect of age and exercise on protanoid concentrations was 
accepted. 
The impact of total cholesterol on prostanoids is 
difficult to evaluate since different cholesterol 
subfractions may have different effects. For example, HDL 
has been associated with an increase in PGI2 synthesis; 
whereas, LDL has been associated with reduced PGI2 
production. (Beitz, & Porster, 1980). No other studies 
investigating the relationship between total serum 
cholesterol and prostanoid responses to acute exercise were 
found. 
No between group differences were found for HDL. 
Therefore, HDL was not used as a covariate. Rauramaa et al. 
(1984) reported that an increase in HDL2 subfraction 
following eight weeks of aerobic exercise training was 
positively correlated with increased plasma pGI2 
concentrations. These researchers also reported that HDL3 
subfractions declined significantly with exercise training. 
One weakness in the present study was that HDL subfractions 
were not evaluated; and, although total serum HDL was 
essentially the same for both groups, one does not know if 
there were any differences in the HDL subfractions. 
There was not a significant difference between LDL values 
for the young and older men, although there was approximately 
a twenty percent difference between the two groups. A weak, 
but significant, inverse correlation was found between LDL 
and the thirty minute post-exercise PGI2/TXA2 ratios (r = -
0.41; p < 0.05). Similar inverse correlations, which 
approached significance, were found between LDL and both 
resting (r = - 0.39; p = 0.059) and immediate post-exercise 
(r = - 0.39; p = 0.060) PGI2/TXA2 ratios. The age group-
related main effect differences between PGI2/TXA2 ratios were 
eliminated when LDL was used as a covariate. The addition 
of LDL as a covariate did not make a significant contribution 
to the analysis. The p-values representing the effect of the 
between subject factor, age-group was (p = 0.101), and the 
regression factor, LDL was (p = 0.115). The hypothesis that 
there would not be a significant difference between PGI2/TXA2 
ratios during rest, exercise or thirty minutes following 
exercise when LDL was used as a covariate remained tenable; 
but, these values suggest that LDL may be related to 
PGI2/TXA2 ratios. The small sample size and the large degree 
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of variability among prostanoid concentrations in both groups 
and among LDL in the older group probably contributed to the 
low r-values and the lack of significance. 
These data seem to suggest that individuals with high 
serum LDL concentrations may have lower PGI2/TXA2 ratios both 
at rest and following exercise, regardless of their age. 
Research by Beitz and Forster (1980) indicated that serum LDL 
from humans inhibited in vitro PGI2 synthesis. Their results 
tend to support the notion that LDL may also alter the 
PGI2/TXA2 ratio. It is difficult to ascertain whether or not 
LDL directly altered PGI2 concentrations in the present 
study. According to Vericel et al. (1988) age is apparently 
positively related to plasma PGI2; whereas, LDL has been 
inversely associated with PGI2 synthesis (Beitz, & Forster, 
1980). Resting PGI2 concentrations in the present study were 
approximately sixteen percent higher in the older men. 
Immediately following exercise and thirty minutes later PGI2 
concentrations were essentially the same in both groups with 
neither group experiencing any significant exercise-induced 
alterations. One might speculate that under resting 
conditions the influence age had on plasma PGI2 was 
predominant, compared to LDL's effect on PGI2. Following 
exercise there were differences in PGI2 concentrations. 
Assessment of the potentially confounding influences age and 
LDL concentrations have on circulating concentrations of PGI2 
and TXA2 is warranted. Additionally, one might measure LDL 
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concentrations during and after acute exercise in order to 
more precisely determine the role of LDL, although there is 
little evidence to suggest that acute exercise has an effect 
on LDL. The present study provides sufficient evidence to 
support further investigation of the influence of LDL on 
prostanoid concentrations during and after exercise. 
Dietary Characteristics 
Mean daily intake of calories, fat and saturated fat 
intake were similar for both groups in the present study. 
Mean daily intake of linoleic acid expressed as a percentage 
of the mean daily intake of calories was not significantly 
different between the two groups. The values were 5.74 + 
0.07% and 4.98 + 0.02% for the young and older group, 
respectively. DuPont (1987) recommended that six to ten 
percent of total daily energy intake come from linoleic acid 
to insure that adequate substrate is available for prostanoid 
synthesis; and, the amount of linoleic acid needed is 
inversely related to P/S ratio. Intake of linoleic acid by 
the two groups in the present study approached the lower end 
of the requirements, but did not meet the recommendations 
made by DuPont (1987). The P/S ratio within each group 
equaled or exceeded the recommended dietary allowance of 1.0. 
The P/S ratios were 1.66 + .36 and 1.00 + .36 for the young 
men and older men, respectively. The linoleic acid intake 
requirements for both the young and older groups were near 
the low end of the percentage of total energy intake range. 
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Whereas dietary linoleic acid values found in the present 
study suggest that intake in both groups may have been 
slightly deficient/ plasma concentrations of both PGI2 and 
TXA2 were within the ranges reported by other researchers 
(Metha, Metha, & Horalek, 1983; Taniguchi, Furui, Yamauchi, 
& Sotobata, 1984). 
One weakness with the results pertaining to linoleic acid 
was that concentrations of this prostanoid substrate were 
estimated via dietary food records. Neither the actual 
intake nor circulating concentrations of linoleic acid were 
measured. 
A significant difference in the mean daily intake of 
polyunsaturated fat was found between the two groups (p < 
0.05). Polyunsaturated fat intake was approximately 48.1% 
higher in the young group. A weak, but significant, 
correlation was found between polyunsaturated fat intake and 
resting PGI2 concentrations. Polyunsaturated fat intake was 
not significantly related to PGI2 at any other observation 
time. Polyunsaturated fat was used a covariate since a 
significant difference was found between the two groups. 
Addition of polyunsaturated fat as covariate did not make a 
significant contribution to the analysis. 
The difference between P/S ratios found in each group 
were not statistically significant. The ratio among the 
young men was 66% greater than that found among the older 
78 
men, but the mean values in the young group was marked by a 
large degree of variability. 
The dietary data did not provide sufficient information 
to help clarify the unique findings in the present study, 
although a significant difference was found between group 
intake of polyunsaturated fat. Dietary information might be 
useful in future research, particularly if larger sample 
sizes are used. 
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CHAPTER VI 
CONCLUSIONS AND RECOMMENDATIONS 
The results of the present study suggest that thirty 
minutes following exercise, some older men may be more 
predisposed to platelet aggregation due to a decline in the 
PGI2/TXA2 ratio. This exercise-induced response was 
characterized by plasma TXA2 concentrations that were nearly 
two-fold greater in the older men compared to the younger 
men. The lack of statistically significant differences 
indicates that further investigation is needed. 
The large degree of variability present in some of 
prostanoid data contributed in part to the fact that no 
statistically significant differences were obtained. Some 
of the variability among the prostanoid values may have been 
related to the relatively wide range of fitness categories 
represented by the subjects. Subjects representing more 
homogenous fitness categories might help eliminate some of 
the variation among the prostanoid data. A greater sample 
size may also help increase the chances of obtaining 
statistically significant differences. 
Total cholesterol and polyunsaturated fat intake were 
significantly different between the two groups; and, LDL and 
P/S ratios approached statistically significant differences. 
The use of total cholesterol, LDL, polyunsaturated fat and 
P/S ratios as covariates did not alter the results for the 
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statistical analysis of the effect of age and exercise on 
prostanoid concentrations. Serum HDL, linoleic acid intake 
and saturated fat intake were similar between both groups. 
Evaluation of each of these parameters should be included in 
future research since other researchers have reported that 
they may help to clarify differences found when evaluating 
circulating concentrations of PGI2 and TXA2. 
Other research suggest that individuals older than those 
involved in the present study may experience greater age-
related increases in circulating prostanoid concentrations. 
Therefore, future research designed to investigate the effect 
of age on TXA2 and PGI2 concentrations should involve 
subjects older than the one's included in this study,. 
Verification of platelet aggregation and evidence of 
platelet activation in the presence of a decline in PGI2/TXA2 
ratios would add strength to the results reported in the 
present study. A number of techniques allowing estimation 
of in vivo platelet aggregation exist; and, measurement of 
beta-thromboglobulin or platelet factor IV would provide 
evidence of platelet activation. If exercise-induced 
increases in TXA2 are associated with increased platelet 
aggregation or activation then the specific TXA2 synthase 
blocker, imidazole, should be used to substantiate this 
relationship. 
Future research should involve the collection of samples 
at several different times during recovery from exercise to 
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determine when TXA2 concentrations peak following exercise. 
The investigation of the effects of different durations and 
intensities of exercise may help clarify which exercise 
conditions are associated with the greatest alterations in 
prostanoid concentrations. Investigations conducted by 
Rauramaa et al. (1984) suggest that exercise training may 
lead to favorable changes in prostanoid synthesis. Future 
research should investigate the effects of exercise training 
on circulating prostanoids in older adults. 
The effect of age and exercise on PGI2/TXA2 ratios were 
investigated in only male subjects in the present study. 
Female subjects were not included because lipid profiles 
between men and women have been found to be significantly 
different; thus, the inclusion of women in the present study 
may have presented an additional confounding factor 
influencing the results. Future research should involve 
comparisons between male and female subjects. 
Further investigation of the interaction between age, 
exercise, lipid profiles and diet and the effect of these 
factors on prostanoids may provide valuable information 
necessary for identifying mechanisms associated with platelet 
aggregation. Such research may also be useful in identifying 
persons at higher risk of exercise-induced thrombosis 
formation. 
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CONSENT FORM FOR HUMAN SUBJECTS (young adults) 
THE UNIVERSITY OF NORTH CAROLINA AT GREENSBORO 
SCHOOL OF HEALTH, PHYSICAL EDUCATION AND RECREATION 
Subject's Name: 
Project Title: Effect of Age and Acute Exercise on 
Circulating Concentrations of Prostacyclin 
and Thromboxane A2 in Adult Males 
Project Coordinator: Mikel Kent Todd, Doctoral Candidate 
Department of Exercise and Sport 
Sciences 
I understand that the purpose of this study is to 
determine if there is a difference between the circulating 
ratio of prostacyclin and thromboxane A2, two substances 
found in the blood that have an important role in platelet 
aggregation. Whereas this study may not directly benefit me, 
it may advance knowledge in the field of exercise physiology 
and medicine. 
I understand that taking aspirin, ibuprofen (Advil, 
Medipren, Motrin or Nuprin), indomethacin (Indocin) or 
similar medications during this study may interfere with the 
results of this study. Thus, I agree not to take any of 
these medications for 1 week prior to the maximal exercise 
test or at any time prior to completion of my participation 
in the study. If I am prescribed any of these medications 
during my participation in this test I will immediately 
notify the project coordinator. I understand that if I do 
need to take an analgesic (pain reliever) while I am a 
participant that I may take one containing acetaminophen 
(Tylenol). 
During the study I will report to the Exercise Physiology 
Laboratory on the UNC-Greensboro campus (HPERD Building #240) 
for 3 visits. During the first visit I will be informed of 
the procedures involved in the study; and, I will be asked 
to answer questions regarding my medical history. I 
understand that between the first visit and the time that I 
complete the study I must use Mazola margarine and cooking 
oil in place of any other margarines or oils I currently use. 
During the second visit I will perform a maximal exercise 
stress test on a motorized treadmill. I understand that 
during this test electrodes will be attached to my torso so 
that my cardiac response to the exercise may be monitored. 
I understand that it may be necessary for the researcher to 
shave hair from my chest to properly attach the electrodes. 
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I understand that during and/or after this test I may become 
dizzy, tired or weak as a result of fatigue. I understand 
that the results from this test will be used to determine the 
intensity levels for the sub-maximal tests. My performance 
on this test will be explained to me afterwards. 
I understand that there is a rare possibility that I may 
suffer a heart attack ( <3 in 10/000) or death ( <1 in 
10,000) as a result of the maximal exercise test, but that 
the researchers will minimize such risk by pre-liminary 
screening and continuous monitoring throughout the test. 
I understand that between the second and third visit I 
will be asked to complete a 4-day dietary food record. I 
understand that within 2 weeks I will return to the lab for 
1 more visit to perform a sub-maximal exercise test at 70% 
to 75% of my maximal oxygen consumption. 
I understand that each sub-maximal test will be conducted 
as follows. I will enter the lab after an overnight fast. 
Upon entering the lab, I will be asked to rest in the supine 
position for 15 minutes. After this rest period 20 
milliliters of blood will be taken from and antecubital vein 
located near the elbow region of my arm. The blood will be 
taken using sterile venipuncture techniques. I understand 
that the venipuncture may be slightly painful and that there 
is a slight risk of infection at the insertion site. I 
understand that the researchers will take precautions to 
prevent infection. To help stop bleeding after the needle 
is removed from my vein I will apply pressure with gauze to 
the venipuncture site until the researcher tells me to stop. 
After the blood sample has been taken, I will remain lying 
down while electrodes are attached to my torso. I will begin 
a 30 minute run on the treadmill at the intensity mentioned 
above. Following the 30 minute run I will cool down on the 
treadmill until my heart rate has dropped to below 110 beats 
per minute. Within 5 minutes after the 30 minute run another 
20 milliliter blood sample will be taken. After I have 
sufficiently cooled down I will rest for 30 minutes. At the 
end of 30 minutes another 20 milliliter blood sample will be 
taken. 
I confirm that my participation in this study is 
voluntary, and that no coercion has been used to obtain my 
cooperation. I also understand that I can terminate my 
participation in this study at any time. I understand that 
all information obtained in this study will remain 
confidential and anonymous. I understand that a summary of 
the results of the study will be made available to me, per 
my request, after the completion of this study. 
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I confirm that I have been informed of the procedures 
that will be used in this study. I understand what is 
required of me as a subject and the risk involved. I agree 
that any questions I have regarding this study and the 
procedures have been answered to my satisfaction; and, I wish 
to give my voluntary cooperation as a participant. 
Questions: 
Responses: 
Signature of Subject 
Address 
Phone Number 
Date 
Witness 
APPENDIX B 
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CONSENT FORM FOR HUMAN SUBJECTS (older adults) 
THE UNIVERSITY OF NORTH CAROLINA AT GREENSBORO 
SCHOOL OF HEALTH, PHYSICAL EDUCATION AND RECREATION 
Subject's Name: 
Project Title: Effect of Age and Acute Exercise on 
Circulating Concentrations of Prostacyclin 
and Thromboxane Aj in Adult Males 
Project Coordinator: Mikel Kent Todd, Doctoral Candidate 
Department of Exercise and Sport Science 
I understand that the purpose of this study is to 
determine if there is a difference between the circulating 
ratio of prostacyclin and thromboxane A2, two substances 
found in the blood that have an important role in platelet 
aggregation. Whereas this study may not directly benefit me, 
it may advance knowledge in the field of exercise physiology 
and medicine. 
I understand that taking aspirin, ibuprofen (Advil, 
Medipren, Motrin or Nuprin), indomethacin (Indocin) or 
similar medications during this study may interfere with the 
results of this study. I agree not to take any of these 
medications for 1 week prior to the maximal exercise test or 
at any time prior to completion of my participation in the 
study. If I am prescribed any of these medications during 
my participation in this test I will notify the project 
coordinator. I understand that if I need to take an 
analgesic (pain reliever) while I am a participant that I may 
take one containing acetaminophen (Tylenol). 
During the study, I will report to the Student Health 
Center at UNC-Greensboro (Room #207) or the Exercise 
Physiology Laboratory in the HPRD Building (Room #240) for 
3 visits. I understand that the researcher will inform me 
about the location where I am supposed to report. During the 
first visit I will be informed of the procedures involved in 
the study; and, I will be asked to answer questions regarding 
my medical history. I understand that between the first 
visit and the time that I complete the study I must use 
Mazola margarine and cooking oil in place of any other 
margarines or oils I currently use. Also, between the first 
and second visit I must meet with my physician. I understand 
that I must ask my physician to for: (1) written permission 
supporting my participation in this study and (2) the release 
of any pertinent medical information to the UNC-Greensboro 
Student Health Center. Documents regarding these issues will 
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be given to me during the first visit and must be returned 
to the project coordinator before I further participate in 
this study. I also understand that a list of 
"Contraindications for Exercise Testing" will be given to me 
to give to my physician, and that my physician will also be 
asked to verify that he or she was provided with this 
information. 
During the second visit I will perform a maximal exercise 
stress test on a motorized treadmill. I understand that 
during the test electrodes will be attached to my torso so 
that my cardiac response to the exercise may be monitored. 
I understand that it may be necessary for the researcher to 
shave hair from my chest to properly attach the electrodes. 
I understand that during and/or after this test I may become 
dizzy, tired or weak as a result of fatigue. I understand 
that the results from this test will be used to determine the 
intensity levels for the sub-maximal tests. My performance 
on this test will be explained to me afterwards. 
I understand that there is a rare possibility that I may 
suffer a heart attack ( <3 in 10,000) or death ( <1 in 
10,000) as a result of the maximal exercise test, but that 
the researchers will minimize such risk by preliminary 
screening and continuous monitoring throughout the test. I 
understand that the maximal test will be conducted either in 
the Student Health Center, where a physician is on the 
premises, or the Exercise Physiology Laboratory, where a 
physician will be directly supervising the test. If the test 
is conducted in the Exercise Physiology Laboratory, the 
Emergency Medical Services will be notified in advance about 
the time, location and nature of the test. I understand that 
if I have a heart attack during the test, cardiopulmonary 
resuscitation (CPR) or defibrillation may used for life 
support. I understand that the life sustaining cardiac 
medications will not be administered until the Emergency 
Medical Services arrive, and that the risk of death from a 
heart attack may be greater during the maximal exercise 
testing at the Exercise Physiology Laboratory than the 
Student Health Center, hospital, or a doctor's office. I am 
aware of the increased risk and accept it as part of my 
participation. I have been assured that American College of 
Sports Medicine Guidelines for Exercise Testing and 
Prescription will be followed during all phases of this 
study. 
I understand that between the second and third visit I 
will complete a 4-day dietary food record. I understand that 
within 2 weeks, I will return for 1 more visit to perform a 
sub-maximal exercise test at 70% to 75% of my maximal oxygen 
consumption which was calculated from the results of my 
maximal exercise test. 
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I understand that each sub-maximal test will be conducted 
as follows. I will enter the lab after an overnight fast. 
Upon entering the lab, I will be asked to rest in the supine 
position for 15 minutes. After this rest period 20 
milliliters of blood will be taken from and antecubital vein 
located near the elbow region of my arm. Blood will be taken 
using sterile venipuncture techniques. I understand that the 
venipuncture may be slightly painful and that there is a 
slight risk of infection at the insertion site. I understand 
that the researchers will take precautions to prevent 
infection. To help stop bleeding after the needle is removed 
from my vein, I will apply pressure with gauze to the 
venipuncture site until the researcher tells me to stop. 
After the blood sample has been taken, I will remain lying 
down while electrodes are attached to my torso. I will begin 
a 30 minute run on the treadmill at 70% to 75% of my maximal 
oxygen consumption. Following the 30 minute run, I will cool 
down on the treadmill until my heart rate has dropped to 
below 110 beats per minute. Within 5 minutes after the 30 
minute run another 20 milliliter blood sample will be taken. 
After I have sufficiently cooled down, I will rest for 30 
minutes. At the end of 30 minutes another 20 milliliter 
blood sample will be taken. 
I confirm that my participation in this study is 
voluntary, and that no coercion has been used to obtain my 
cooperation. I also understand that I can terminate my 
participation in this study at anytime. I understand that 
all information obtained in this study will remain 
confidential and anonymous. I understand that a summary of 
the results of the study will be made available to me, per 
my request, after the completion of this study. 
I confirm that I have been informed of the procedures 
that will be used in this study. I understand what is 
required of me as a subject and the risk involved. I agree 
that any questions I have regarding this study and the 
procedures have been answered to my satisfaction; and, I wish 
to give my voluntary cooperation as a participant. 
Questions: 
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Responses: 
Signature of Subject Phone Number 
Address Date 
Witness 
APPENDIX C 
(Medical History) 
Medical History 
History of Cardiovascular Disease: 
Heart attack 
Chest discomfort 
Heart murmurs 
Extra or skipped beats 
Congenital heart disease 
Cardiac surgery 
Peripheral Vascular Disease 
Rheumatic Fever 
Phelbitis, emoboli 
Unusual shortness of breath 
Major Coronary Risk Factors: 
History of high blood pressure (145/95) 
Elevated TC/HDL ratio 
Smoking 
Abnormal resting ECG 
Family history of CHD prior to age 50 
Diabetes 
Other Factors: 
Ankle swelling 
Pulmonary disease (asthma, emphysema and 
bronchitis) 
Lightheadedness or fainting 
Emotional disorders 
Stroke 
Recent illness or hospitalization 
Orthopedic problems 
Caffine intake (including colas) 
Dieting 
Exercise History: (Type/Intensity/Duration/Frequency) 
Medications: 
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(Physician's Disclosure and Approval Statement) 
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Physician's Disclosure and Approval for Participation 
1/ , based on my 
professional assessment, hereby agree that, 
, otherwise known as the research subject, can 
safely participate in the dissertation research to be 
conducted by Mikel Kent Todd at the Student Health Center at 
the University of North Carolina at Greensboro. I confirm 
that as part of my assessment I have reviewed the research 
subject's medical history. I understand that as a 
participant in this study the research subject will 
participate in both a maximal exercise stress test and a sub-
maximal exercise session. I understand that.both exercise 
sessions will be performed an a motorized treadmill with 
continuous 12-lead electorcardiographic monitoring. I 
understand that a physician will be in the Student Health 
Center building during the testing, that the physician will 
be alerted to the fact that the testing is underway and that 
the physician will be available for any emergency situations 
that may arise as a result of the testing. I understand the 
sub-maximal exercise session will be 30 minutes in duration 
and that the research subject will exercise at 70 to 75% of 
his maximal oxygen consumption. I confirm that (1) I am 
aware of the risk associated with exercise testing (2) the 
research subject has provided me with the list of 
"Contraindications for Exercise Testing" and a resting 12-
lead electrocardiograph and (3) I have reviewed these 
documents. 
Right to Release Medical Information 
I, , have granted the 
physician, , permission to 
provide the Student Health Center physicians at the 
University of North Carolina at Greensboro with any pertinent 
medical information necessary to safely treat me during any 
medical emergency arising as a result of my participation in 
the exercise testing portion of the dissertation research 
conducted by Mikel Kent Todd. 
I, , otherwise known as the 
subject's physician, agree to provide the Student Health 
Center physicians at the University of North Carolina at 
Greensboro with any pertinent medical information necessary 
to safely treat, , the 
research subject, during any medical emergency arising as a 
result of participation in the dissertation research 
conducted by Mikel Kent Todd. 
physician's signature 
research subject's signature 
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date 
date 
physician's office phone # other day time phone # 
APPENDIX E 
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Contraindications to Exercise Testing 
"There are certain individuals for whom the risks of 
testing outweigh the potential benefits. These individuals 
should not be tested. There are other individuals whose 
medical conditions increase the risk of testing. It is 
important in these circumstances for the test administrator 
to weigh carefully the anticipated benefits and determine 
that these outweigh the risk." 
Table I. DEFINITE CONTRAINDICATIONS TO EXERCISE TESTING 
1. Recent acute myocardial infarction 
2. Unstable angina 
3. Uncontrolled ventricular dysrhythmia 
4. Uncontrolled atrial dysrhythmia which compromises 
cardiac function 
5. Congestive heart failure 
6. Severe aortic stenosis 
7. Suspected or known dissecting aneurysm 
8. Active or suspected myocarditis 
9. Thrombophlebitis or intracardiac thrombi 
10. Recent systemic or pulmonary embolus 
11. Acute infection 
12. Third degree heart block 
13. Significant emotional distress (psychosis) 
14. Recent significant change in the resting ECG 
15. Acute pericarditis 
Table II. RELATIVE CONTRAINDICATIONS TO EXERCISE TESTING 
1. Resting diastolic blood pressure over 120 mm Hg or 
resting systolic blood pressure over 200 mm Hg 
2. Moderate valvular heart disease 
3. Digitalis or other drug effect 
4. Electrolyte abnormalities 
5. Fixed rate artificial pacemaker 
6. Frequent of complex ventricular irritability 
7. Ventricular aneurysm 
8. Cardiomyopathy including hypertrophic cardiomyopathy 
9. Uncontrolled metabolic disease (diabetes, 
thyrotoxicosis, myxedema, etc.) 
10. Any serious systemic disorder (mononucleosis, 
hepatitis, etc.) 
11. Neuromuscular, musculoskeletal, or rheumatoid 
disorders which would make exercise dangerous or 
difficult 
*From the Guidelines for Exercise Testing and Exercise 
Prescription, American College of Sports Medicine. (1986). 
APPENDIX F 
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MAXIMAL EXERCISE TEST RECORD 
Has the subject provided informed consent? 
Has the physician approved particiaption? 
Name: Date: 
yes no 
yes no 
Age: Age predicted maximal heart rate 
Stage (min) 
Rest 
II 
III 
IV 
V 
VI 
VII 
spd/grd HR BP VO, Remarks 
IPE 
Recovery {2) 
Recovery (5) 
' 1 t « ' 
Comments: 
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Subject's Name: 
SUMMARY OP HOW TO RECORD FOOD PORTIONS 
Record in Ounces: {1 cup = 8 ounces; 1 pint = 16 ounces) 
Beverages - all types, including alcoholic 
Record in Cups or Servings: (small or large serving) 
Potatoes, rice, etc. 
Fruits, vegetables (cooked or canned) 
Soups, cereals, casserole dishes 
Record in Teaspoons or Tablespoons: 
(3 teaspoons = 1 tablespoon) 
Jelly, jam, sugar, syrup 
Salad dressing, sauces, gravies 
Butter, margarine (may list as no. of pats) 
Record by Number and Size: 
Bread, rolls, crackers 
Raw fruits and vegetables 
Meat cuts, chicken, frankfurters, shellfish 
Snack items - nuts, cookies, candy, etc. 
Record by Servings: (small or large serving) 
Pie, cake, coffee cake 
Pizza 
FOOD PREPARATION NOTES 
To be completed by the person preparing meals at home. 
1. Kind of cooking fat used: 
Type Brand Name 
2. Salad dressing used: 
Type Brand Name 
3. Was fat used to cook vegetables? Yes No 
Type 
4. Spread used on bread: 
Type Brand Name 
5. Was milk used in cooking? Yes No % fat 
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6. Fat used in baking: 
Subject's Name: 
Day: 
Type Brand Name 
Date: 
Was this an unusual day? Yes No 
If yes, please explain: 
Time 
At Home 
or Out What You Ate and How Much 
APPENDIX H 
(Sub-maximal Exercise Session Record) 
SUB-MAXIMAL EXERCISE SESSION RECORD 
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Name : Date; 
Age: Target Heart Rate Range: 
VO ̂nax: (ml/kg/min) VO? range: 
Time (min) : spd/grd HR BP VO? I Remarks 
Rest 
10 
15 
20 
2 5  
30 
Recovery (2) 
Recovery (5) 
Comments: 
APPENDIX I 
(Raw and Computed Data; with Codes) 
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Raw and Computed Data Codes 
ID: subject identification code 
Age: age (years). 
Weight: weight (lbs). 
RHR: resting heart rate; lowest heart rate recorded 
(bpm). 
MHR: peak heart rate during maximal exercise test 
(bpm). 
HR5: 5 minute heart rate during sub-ma*imal exercise 
(bpm). 
HR10: 10 minute heart rate during sub-maximal 
exercise (bpm). 
HR15 15 minute heart rate during sub-maximal 
exercise (bpm). 
HR20: 20 minute heart rate during sub-maximal 
exercise (bpm). 
HR25: 25 minute heart rate during sub-maximal 
exercise (bpm). 
HR30: 30 minute heart rate during sub-maximal 
exercise (bpm). 
V02max: maximal oxygen consumption (ml/kg/min). 
V025: mean VO2 recorded between 5 & 10 min during 
sub-maximal exercise (ml/kg/min). 
V0220: mean VO, recorded between 20 & 25 min during 
sub-maximal exercise (ml/kg/min). 
%VO?5: %V025 = v025 / V02max 
%V0220: %V0220 = V0220 / V02max 
TC: total cholesterol (mg/dl). 
HDL: high density lipoprotein (mg/dl). 
LDL: low density lipoprotein (mg/dl). 
Hctl: resting hematocrit. 
Hct2: exercise hematocrit. 
Hct3: recovery hematocrit. 
Hgbl: resting hemoglobin (g/dl). 
Hgb2: exercise hemoglobin (g/dl). 
Hgb3: recovery hemoglobin (g/dl). 
PCI: resting platelet count (x 1000/ml). 
APC2: exercise platelet count adjusted for 
hemoconcentration (x 1000/ml). 
APC3: recovery platelet count adjusted for 
hemoconcentration (x 1000/ml). 
PVB: resting plasma volume. 
%PVE: exercise plasma volume as a percentage of 
resting plasma volume. 
%PVR: recovery plasma volume as a percentage of 
resting plasma volume. 
PGI1: resting 6-keto-Prostaglandin P-, . 
PGI2: exercise 6-keto-Prostaglandin F-, . 
AP612: APGI2 = PGI2 * (%PVE) 
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Raw and Computed Data Codes (continued). 
PGI3: 
APGI3: 
TXA1: 
TXA2: 
ATXA2: 
ApcTXA2: 
ATXA3: 
ApcTXA3: 
B-ratio: 
E-ratio: 
Epc-rat: 
R-ratio: 
Rpc-rat: 
ADPG: 
ADC: 
ADSFG: 
ADPFG: 
PSR: 
ADLA: 
recovery 6-keto-Ptostaglandin F-, . 
APGI3 = PGI3 * (%PVR) 
resting Thromboxane B, . 
exercise Thromboxane fL • 
ATXA2 = TXA2 * (%PVE) 
ApcTXA2 = ATXA2 * (APC2 / PCI) 
ATXA = TXA * (%PVR) 
ApcTXA2 = ATXA3 * (APC3 / PCI) 
B-ratio = PGI1 / TXA1 
E-ratio = APGI2 / ATXA2 
Epc-rat = APGI2 / ApcTXA2 
R-ratio = PGI3 / ATXA3 
Rpc-rat = PGI3 / ApcTXA3 
Average Daily Intake of Fat in Grams 
Average Daily Intake of Calories 
Average Daily Intake of Saturated Fat in Grams 
Average Daily Intake of Polyunsaturated Fat in 
Grams 
Polyunsaturated/Saturated Fat Ratio 
Average Daily Intake of Lenoleic Acid expressed 
as a percentage of ADC. 
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Raw and Computed Data (young adults) 
ID Y2 Y3 Y4 Y5 Y6 Y7 Y8 Y9 Y10 Yll 
Age 25 25 29 25 31 26 29 25 28 32 
Weight 148 136 150 135 131 148 197 163 155 152 
RHR 104 69 56 66 76 67 — 91 74 86 
MHR 206 199 196 192 199 200 185 190 191 
HR5 145 156 158 138 160 135 165 163 
HR10 185 150 156 158 150 162 140 170 150 168 
HR15 185 155 156 166 153 165 142 173 153 163 
HR20 185 155 156 170 153 170 152 176 156 168 
HR25 197 162 158 170 162 173 151 180 160 170 
HR30 165 162 170 165 174 180 163 173 
V02max 50.5 57.3 52.6 58.1 66.8 41.1 60.2 54.5 55.7 41.3 
V025 36.1 42.0 37.0 42.0 38.2 29.6 41.6 39.8 36.5 31.2 
V0220 37.5 42.3 37.8 43.5 46.0 31.2 43.7 40.5 39.8 31.0 
%V025 .72 .73 .70 .72 .57 .72 .69 .73 .65 .76 
%V0220 .74 .74 .72 .75 .69 .77 .73 .74 .71 .75 
TC 196 137 186 197 165 218 150 135 162 182 
HDL 49 42 50 57 39 92 48 42 58 35 
LDL 133 80 119 126 114 114 88 82 91 108 
Hctl .461 .433 .417 .457 .466 .455 .499 .449 .456 .516 
Hct2 .468 .461 .413 .467 .502 .478 .522 .467 .460 .533 
Hct3 .458 .440 .380 .466 .462 .431 .491 .441 .434 .413 
Hgbl 16.1 11.0 15.2 16.0 12.0 16.2 13.4 11.0 15.6 16.4 
Hgb2 16.7 11.9 15.0 16.6 12.5 16.7 13.6 11.4 15.3 16.5 
Hgb3 15.9 11.0 13.0 15.6 12.0 15.2 14.3 10.7 15.1 16.4 
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Yll 
291 
397 
283 
48.4 
0.96 
1.01 
384 
448 
430 
520 
523 
82 
54 
52 
71 
76 
76 
74 
4.7 
8.3 
6.1 
6 . 8  
7.0 
Raw and Computed Data (young adults) cont. 
Y2 Y3 Y4 Y5 Y6 Y7 Y8 Y9 Y10 
272 276 210 261 325 292 250 228 321 
277 255 272 271 332 314 275 261 361 
269 273 228 232 338 305 214 202 346 
53.9 56.7 58.3 54,3 53.4 54.5 50.1 55.1 54.4 
0.95 0.88 1.02 0.95 0.89 0.95 0.94 0.94 1.01 
1.02 0.99 1.24 1.01 1.01 1.11 0.96 1.05 1.08 
400 476 380 240 164 112 140 920 460 
459 880 464 344 256 284 220 540 620 
438 771 437 326 228 269 207 505 627 
374 336 272 252 216 280 364 352 376 
381 332 338 255 218 311 348 368 404 
82 52 30 18 30 54 42 102 40 
152 25 29 136 24 22 36 34 30 
145 22 30 129 21 21 34 32 30 
148 20 38 134 22 22 37 36 34 
82 92 38 52 20 32 68 68 50 
84 91 47 53 20 36 65 71 54 
83 90 51 48 21 37 56 63 58 
4.8 9.2 12.7 13.3 5.5 2.1 3.3 9.0 11.5 
3.0 35.2 16.0 2.5 10.7 12.9 6.1 15.9 20.7 
3.0 38.1 12.3 2.4 10.5 12.0 5.5 13.9 18.3 
4.6 3.7 7.2 4.9 10.8 8.8 5.4 5.2 7.5 
4.6 3.7 6.6 5.5 10.4 8.4 6.2 5.9 7.0 
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Raw and Computed Data (young adults) cont. 
ID Y2 Y3 Y4 Y5 Y6 Y7 Y8 Y9 Y10 Yll 
ADFG 80 74 97 131 57 58 110 127 59 61 
ADC 3101 2195 2739 2485 1542 2185 4069 3145 2281 1957 
ADSFG 22.2 30.2 14.8 58.9 26.3 19.1 32.2 32.5 16.0 12.3 
ADPFG 30.8 15.8 48.7 35.3 16.2 27.8 41.0 51.5 18.7 44.0 
ADLA 0.02 0.03 0.05 0.07 0.02 0.03 0.04 0.03 0.03 0.06 
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Raw and Computed Data (older adults) 
ID 01 02 03 04 05 06 07 08 09 010 
Age 55 62 55 55 50 62 52 52 58 60 
Weight 202 150 201 158 204 144 176 176 167 194 
RHR 68 58 94 53 74 62 53 62 66 70 
NHR 162 140 185 175 174 158 170 177 177 163 
HR5 128 123 132 128 140 147 132 119 
HRIO 131 122 139 123 148 148 138 129 
HR15 134 122 152 119 148 153 142 130 
HR20 134 123 153 120 151 155 150 133 
HR25 138 122 155 126 152 158 152 137 
HR30 139 122 162 122 152 156 153 137 
V02max 40.3 45.8 30.2 52.3 38.8 44.7 39.3 40.1 47.1 28.5 
V025 30.2 34.7 16.9 37.8 26.5 31.7 39.9 30.2 30.8 19.4 
V0220 31.3 37.0 22.1 29.1 30.2 30.4 30.4 33.2 21.4 
%V025 .75 .76 .56 .72 .68 .71 .76 .75 .65 .68 
%V0220 .78 .81 .73 .75 .68 .77 .76 .71 .75 
TC 223 192 244 228 285 227 187 173 164 232 
HDL 56 62 — 70 38 64 56 43 52 42 
LDL 115 120 141 195 148 121 109 75 152 
Hctl .467 .443 .455 .433 .490 .443 .475 .476 .486 .472 
Hct2 .482 .469 .446 .404 .510 .418 .476 .479 .498 .488 
Hct3 .459 .448 .437 .427 .432 .429 .438 .441 .470 .458 
Hgbl 16.6 16.3 15.0 15.0 15.0 16.1 16.4 18.7 15.3 14.6 
Hgb2 17.8 16.1 15.0 15.5 17.4 16.0 17.2 18.0 14.8 15.7 
Hgb3 15.2 14.0 14.3 15.2 17.6 14.2 16.4 15.9 15.8 16.1 
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Raw and Computed Data (older adults) cont. 
ID 01 02 03 04 05 06 07 08 09 010 
PCI 241 219 266 317 270 212 286 293 275 257 
APC2 280 310 346 436 307 229 283 361 315 308 
APC3 288 272 333 432 345 228 282 377 276 225 
PVB 53.3 55.7 54.5 56.7 51.0 55.7 52.5 52.4 51.4 52.8 
%PVE 0.91 0.97 1.01 1.01 0.83 1.05 0.95 1.03 1.01 0.90 
%PVR 1.11 1.15 1.08 1.00 0.95 1.16 1.09 1.25 1.00 0.93 
PGI1 204 808 392 168 196 304 336 448 820 848 
PGI2 376 480 380 500 256 396 352 360 420 400 
APGI2 342 464 386 507 212 415 336 370 425 360 
PGI3 228 728 320 432 248 384 232 116 488 528 
APGI3 253 840 346 431 236 444 253 145 488 490 
TXA1 34 96 35 82 60 80 56 52 100 212 
TXA2 25 74 34 64 46 122 34 56 114 72 
ATX A 2 23 71 34 65 38 128 32 58 115 65 
ApcTXA2 26 101 45 89 43 138 32 71 132 78 
TXA3 38 40 163 68 82 64 76 38 100 164 
ATX A 3 42 46 173 68 78 74 83 48 100 152 
ApcTXA3 51 57 216 93 100 80 82 61 100 133 
B-ratio 6.0 8.4 11.2 2.1 3.3 3.8 6.0 8.6 8.2 4.1 
E-ratio 15.0 6.5 11.2 7.8 5.6 3.3 10.4 6.4 3.7 5. < 
Epc-rat 12.9 4.6 8.6 5.7 4.9 3.0 10.5 5.2 3.2 4.1 
R-ratio 6.0 18.2 2.0 6.4 3.0 6.0 3.1 3.1 4.9 3.; 
Rpc-rat 5.0 14.7 1.6 4.7 2.4 5.6 3.1 2.4 4.9 3.: 
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Raw and Computed Data (older adults) cont. 
ID 01 02 03 04 05 06 07 08 09 010 
ADFG 65 49 103 142 101 82 69 48 46 97 
ADC 2287 2534 3002 2857 2298 3605 1717 1875 1682 2312 
ADSFG 19.4 14.4 33.6 26.6 24.5 23.4 18.5 15.4 13.8 29.2 
ADPFG 21.4 13.0 21.8 34.8 27.8 26.2 28.5 11.7 09.5 20.2 
ADLA 0.03 0.02 0.04 0.03 0.04 0.03 0.04 0.03 0.03 0.03 
